ticlopidine has been researched along with Complication, Postoperative in 313 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to compare preoperative treatment using clopidogrel and ticagrelor for patients with acute myocardial infarction (AMI) undergoing emergent percutaneous coronary intervention (PCI), and to investigate the efficacy and safety of these medications in the management of AMI." | 9.20 | Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Zhang, N; Zhang, Q; Zhu, K, 2015) |
| "There were two episodes of thromboembolism in the ticlopidine group at 1 month and 6 months respectively, with a linearized incidence of 0." | 9.08 | Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. ( Agredo, J; Aramendi, JL; Larrarte, C; Llorente, A; Pijoan, J, 1998) |
| "It is unknown whether pretreatment with clopidogrel in acute coronary syndrome (ACS) managed invasively, is superior to a strategy of administering clopidogrel in the cardiac catheterization laboratory at the time of percutaneous coronary intervention (PCI)." | 8.95 | Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. ( Mukherjee, D; Naidu, SS; Nairooz, R; Pothineni, NV; Raina, S; Rochlani, Y; Sardar, P; Shavelle, DM; Valgimigli, M, 2017) |
| "Variable response to clopidogrel can impact perioperative risk in elective endovascular intracranial aneurysm treatment." | 7.85 | Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response. ( Delgado Almandoz, JE; Fease, JL; Kayan, Y; Milner, AM; Mulder, M; Scholz, JM, 2017) |
| "There is a known bleeding risk with administration of the antiplatelet drug clopidogrel, but in certain patients the likelihood of thrombosis is too high to cease its administration perioperatively." | 7.81 | Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series. ( Bono, J; Nandi, S; Shubert, D, 2015) |
| "Although randomized clinical trials have compared clopidogrel with higher potency ADP receptor inhibitors (ADPris) among patients with myocardial infarction, little is known about the frequency and factors associated with switching between ADPris in clinical practice." | 7.80 | In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. ( Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y, 2014) |
| "The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown." | 7.80 | Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014) |
| " We aimed to determine the relationship between high on-treatment platelet reactivity (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel." | 7.78 | Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. ( Armero, S; Barragan, P; Berbis, J; Bessereau, J; Bonello, C; Bonello, L; Camillieri, E; Camoin-Jau, L; Dignat-George, F; Jacquin, L; Laine, M; Paganelli, F, 2012) |
| "To identify factors related to thromboembolic events during coil embolization for unruptured intracranial aneurysms and to evaluate the role of clopidogrel premedication to prevent thromboembolisms." | 7.76 | Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? ( Han, MH; Jung, C; Kang, HS; Kim, JE; Kwon, BJ; Kwon, OK; Oh, CW, 2010) |
| " The objective of this study is to assess the relationship between response to clopidogrel and post-treatment platelet reactivity (PPR) and 1-year major adverse cardiovascular events (MACE) in patients with non-ST segment elevation acute coronary syndrome (NSTEACS)." | 7.75 | Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. ( Alonso Orcajo, N; Alonso Rodríguez, D; Carbonell de Blas, R; Cuellas Ramón, C; de Miguel Castro, A; Diego Nieto, A; Fernández Vázquez, F; Pascual Vicente, C; Pérez de Prado, A; Samaniego Lampón, B, 2009) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 7.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| " Combined major adverse cardiovascular event (stroke, MI, and death) was not different in the two groups (OR 1." | 6.47 | Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. ( Athanasiou, T; Malik, IS; Nijjer, SS; Watson, G, 2011) |
| "Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
| " However, it is unclear whether antiplatelet monotherapy with ticagrelor alone versus ticagrelor plus aspirin reduces the incidence of clinically relevant bleeding without increasing the risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in ACS patients undergoing percutaneous coronary intervention (PCI) with DES implantation guided by either intravascular ultrasound (IVUS) or angiography who have completed a 1-month course of DAPT with aspirin plus ticagrelor." | 5.41 | Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice ( Chen, F; Chen, SL; Gao, DS; Gao, XF; Ge, Z; Han, YL; He, YQ; Kan, J; Kong, XQ; Li, F; Lin, S; Liu, ZZ; Qian, XS; Qu, H; Shao, YB; Tao, L; Tian, NL; Wang, Y; Wang, ZZ; Wen, SY; Xia, Y; Xiao, PX; Yang, Q; Yang, S; Ye, F; Zeng, HS; Zhang, JJ; Zuo, GF, 2021) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 5.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| "Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease." | 5.31 | Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report. ( Buyukberber, S; Sari, R; Sevinc, A, 2000) |
| "In the PRODIGY trial, prolonging clopidogrel-based DAPT beyond six months in elderly patients increased the risk of bleeding, without affording a significant prevention of ischaemic events." | 5.24 | Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial. ( Ariotti, S; Franzone, A; Gargiulo, G; Heg, D; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Tebaldi, M; Valgimigli, M; Windecker, S, 2017) |
| "Previous studies evaluating correlates of stent thrombosis (ST) have included mostly patients with bare metal stents and early-generation drug-eluting stents (DES) and have not systematically evaluated the role of intravascular ultrasound-guided stenting and high platelet reactivity on clopidogrel." | 5.20 | Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES. ( Brodie, BR; Garg, A; Kirtane, AJ; Maehara, A; Mehran, R; Metzger, DC; Neumann, FJ; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B, 2015) |
| "Rates of bleeding and thrombotic events were not significantly different according to 6- versus 24-month DAPT after PCI with new-generation DES in good aspirin responders." | 5.20 | 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. ( Armengaud, J; Barragan, P; Benamer, H; Berland, J; Blanchard, D; Boschat, J; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Druelles, P; Dupouy, P; Endresen, K; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J, 2015) |
| "This study aimed to compare preoperative treatment using clopidogrel and ticagrelor for patients with acute myocardial infarction (AMI) undergoing emergent percutaneous coronary intervention (PCI), and to investigate the efficacy and safety of these medications in the management of AMI." | 5.20 | Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Zhang, N; Zhang, Q; Zhu, K, 2015) |
| " Furthermore, the simpler dosing regimen, the absence of neutropenia, and the lower frequency of other side effects make it a safe alternative to ticlopidine." | 5.09 | Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. ( Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X, 1999) |
| "There were two episodes of thromboembolism in the ticlopidine group at 1 month and 6 months respectively, with a linearized incidence of 0." | 5.08 | Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. ( Agredo, J; Aramendi, JL; Larrarte, C; Llorente, A; Pijoan, J, 1998) |
| "Previous studies have shown that stents can be inserted in coronary arteries of patients who are subsequently treated safely with antiplatelet therapy only (ticlopidine and/or aspirin) with a low incidence of stent thrombosis, provided that stent expansion is adequate and there are no other flow-limiting lesions present." | 5.08 | Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. ( Albiero, R; Blengino, S; Colombo, A; Ferraro, M; Hall, P; Itoh, A; Martini, G; Nakamura, S, 1997) |
| " A 5-day course of ticlopidine HCl immediately before surgery results in a significant reduction in the thrombopenia usually observed and attributed to platelet aggregation and adhesion to the apparatus." | 5.05 | [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)]. ( Curtet, JM; Guilmet, D; Renner, C, 1980) |
| "It is unknown whether pretreatment with clopidogrel in acute coronary syndrome (ACS) managed invasively, is superior to a strategy of administering clopidogrel in the cardiac catheterization laboratory at the time of percutaneous coronary intervention (PCI)." | 4.95 | Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. ( Mukherjee, D; Naidu, SS; Nairooz, R; Pothineni, NV; Raina, S; Rochlani, Y; Sardar, P; Shavelle, DM; Valgimigli, M, 2017) |
| "Dual antiplatelet therapy with acetylsalicylic acid (aspirin) and clopidogrel is a guideline-recommended standard of care for patients with acute coronary syndromes (ACS) and those who undergo percutaneous coronary intervention (PCI)." | 4.88 | Clopidogrel: the data, the experience, and the controversies. ( Sadanandan, S; Singh, IM, 2012) |
| "In patients with acute coronary syndromes undergoing percutaneous coronary intervention, the combination of aspirin and clopidogrel, a P2Y12 adenosine diphosphate (ADP) receptor antagonist, is the gold standard of antiplatelet therapy." | 4.88 | Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention. ( Bessereau, J; Bonello, L; Camoin-Jau, L; Paganelli, F; Uhry, S, 2012) |
| " Premature withdrawal of dual antiplatelet therapy carries a substantial risk of stent thrombosis but perioperative continuation of dual antiplatelet therapy is associated with an increased risk of bleeding, particularly in patients treated with the new potent drugs prasugrel and ticagrelor." | 4.88 | [Platelet function: new drugs, new assays : possible impacts on operative medicine?]. ( Freynhofer, MK; Höchtl, T; Huber, K; Mahla, E; Prüller, F, 2012) |
| "Clopidogrel has become part of the mainstay of therapy for acute coronary syndromes and in patients post stenting." | 4.87 | Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy. ( Dart, AM; Fernando, H; Peter, K; Shaw, JA, 2011) |
| "The use of ticlopidine in association with aspirin has reduced the incidence of subacute stent thrombosis to currently < 1% after coronary stent implantation." | 4.82 | [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?]. ( Baralis, G; Dellavalle, A; La Scala, E; Steffenino, G; Uslenghi, E, 2003) |
| "The present study is an investigation of the association between high on-treatment platelet reactivity to clopidogrel (HTPRC) and hepatosteatosis in patients who had elective stent implantation due to coronary artery disease." | 3.88 | Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation. ( Alper, AT; Barutca, H; Bora Şişman, S; Bozbeyoğlu, E; Çakıllı, Y; Çinier, G; Güzelburç, Ö; Şahin, S; Tekkeşin, Aİ; Velibey, Y; Yıldırımtürk, Ö, 2018) |
| "Variable response to clopidogrel can impact perioperative risk in elective endovascular intracranial aneurysm treatment." | 3.85 | Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response. ( Delgado Almandoz, JE; Fease, JL; Kayan, Y; Milner, AM; Mulder, M; Scholz, JM, 2017) |
| "There is a known bleeding risk with administration of the antiplatelet drug clopidogrel, but in certain patients the likelihood of thrombosis is too high to cease its administration perioperatively." | 3.81 | Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series. ( Bono, J; Nandi, S; Shubert, D, 2015) |
| "Although randomized clinical trials have compared clopidogrel with higher potency ADP receptor inhibitors (ADPris) among patients with myocardial infarction, little is known about the frequency and factors associated with switching between ADPris in clinical practice." | 3.80 | In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. ( Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y, 2014) |
| "The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown." | 3.80 | Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014) |
| " The aim of this study was to ascertain whether it is necessary to stop clopidogrel preoperatively to avoid postoperative complications following hip hemiarthroplasty surgery in patients with intracapsular hip fracture." | 3.79 | Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. ( Hossain, FS; Koch, L; Rambani, R; Ribee, H, 2013) |
| " The aim of this study was to investigate if platelet inhibition by clopidogrel has an influence on the formation of obliterative bronchiolitis, the histopathological correlate to bronchiolitis obliterans syndrome, present in the majority of patients suffering from CLAD." | 3.79 | Clopidogrel reduces post-transplant obliterative bronchiolitis. ( Eckl, S; Ensminger, SM; Koch, N; Preidl, RH; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M, 2013) |
| "In primary angioplasty, bivalirudin is superior to treatment with heparin plus glycoprotein inhibitors for reducing cardiovascular events, although bivalirudin increases the risk of stent thrombosis." | 3.79 | A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching. ( Acosta, J; Benezet, J; Cubero Gómez, JM; Díaz DE LA Llera, LS; Fernández-Cisnal, A; Parejo, J; Rangel, D; Zafra, F, 2013) |
| "Patients with recent acute coronary syndrome or percutaneous coronary intervention prescribed clopidogrel were offered CYP2C19 testing." | 3.79 | Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention. ( Brennan, T; Canestaro, WJ; Chaplin, D; Choudhry, NK; Desai, NR; Kyrychenko, P; Martell, LA; Matlin, OS, 2013) |
| " We aimed to determine the relationship between high on-treatment platelet reactivity (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel." | 3.78 | Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. ( Armero, S; Barragan, P; Berbis, J; Bessereau, J; Bonello, C; Bonello, L; Camillieri, E; Camoin-Jau, L; Dignat-George, F; Jacquin, L; Laine, M; Paganelli, F, 2012) |
| "To identify factors related to thromboembolic events during coil embolization for unruptured intracranial aneurysms and to evaluate the role of clopidogrel premedication to prevent thromboembolisms." | 3.76 | Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? ( Han, MH; Jung, C; Kang, HS; Kim, JE; Kwon, BJ; Kwon, OK; Oh, CW, 2010) |
| " The objective of this study is to assess the relationship between response to clopidogrel and post-treatment platelet reactivity (PPR) and 1-year major adverse cardiovascular events (MACE) in patients with non-ST segment elevation acute coronary syndrome (NSTEACS)." | 3.75 | Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. ( Alonso Orcajo, N; Alonso Rodríguez, D; Carbonell de Blas, R; Cuellas Ramón, C; de Miguel Castro, A; Diego Nieto, A; Fernández Vázquez, F; Pascual Vicente, C; Pérez de Prado, A; Samaniego Lampón, B, 2009) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 3.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| " A significant increase in postoperative hemorrhage and a higher percentage of reoperations for this reason was observed in the patients treated with ticlopidine." | 3.67 | Ticlopidine as a hemorrhagic risk factor in coronary surgery. ( Avello, F; Carmona, J; Criado, A; Juffé, A; Otero, C, 1985) |
| "Myocardial infarction was assessed using the third universal definition." | 2.82 | Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. ( Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN, 2016) |
| "Our study offers preliminary evidence that patients receiving a new PCI procedure for ISR may benefit from long-term administration of aspirin plus clopidogrel." | 2.79 | Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). ( Biscaglia, S; Campo, G; Ferrari, R; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P, 2014) |
| " The PRASugrel For Japanese PatIenTs with Coronary Artery Diseases Undergoing Elective PCI (PRASFIT-Elective) study investigated the efficacy and safety of different prasugrel dosing regimens in Japanese patients undergoing elective PCI." | 2.79 | Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. ( Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H, 2014) |
| "Transplant renal artery stenosis is a major complication that requires a therapeutic approach involving surgery or angioplasty." | 2.77 | Angioplasty and stent treatment of transplant renal artery stenosis. ( Ballarín, J; Canal, C; de la Torre, P; Del Pozo, M; Díaz, JM; Facundo, C; Guirado, L; Martí, J, 2012) |
| "A cause other than paradoxical embolism was usually apparent in patients with recurrent neurologic events." | 2.77 | Closure or medical therapy for cryptogenic stroke with patent foramen ovale. ( Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L, 2012) |
| " Higher dosing strategies and methods to confirm platelet inhibition should be further investigated in order to optimally use clopidogrel in patients undergoing stenting." | 2.71 | The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. ( Bliden, KP; Gurbel, PA; Hayes, KM; Herzog, WR; Tantry, US; Yoho, JA, 2005) |
| "Ticlopidine pretreatment did not significantly influence the risk of death or myocardial infarction in patients randomized to abciximab." | 2.70 | Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. ( Ellis, SG; Lincoff, AM; Steinhubl, SR; Topol, EJ; Wolski, K, 2001) |
| "Probucol is a lipid-lowering drug that has an antioxidant effect." | 2.70 | Effect of antioxidant probucol for preventing stent restenosis. ( Cha, KS; Han, JY; Kim, HJ; Kim, JS; Kim, MH, 2002) |
| " Side-effects of ticlopidine were rare and patient management with the standard dosage of this drug was easier than oral anticoagulation." | 2.66 | Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion. ( Goebel, N; Krayenbühl, HP; Pfluger, N; Rothlin, ME; Senning, A; Speiser, K; Steinbrunn, W; Turina, M, 1985) |
| "Ticlopidine is an effective inhibitor of platelet aggregation." | 2.66 | Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. ( Gröntoft, KC; Gutierrez, A; Mulec, H; Olander, R, 1985) |
| " Combined major adverse cardiovascular event (stroke, MI, and death) was not different in the two groups (OR 1." | 2.47 | Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. ( Athanasiou, T; Malik, IS; Nijjer, SS; Watson, G, 2011) |
| "Intertrochanteric fractures are common in the elderly, who also suffer from a number of comorbidities." | 1.46 | Poor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort study. ( Chen, X; Liu, Z; Ren, J; Sun, T; Wang, J; Wang, X; Zhang, J, 2017) |
| "Oropharyngeal bleeding and dehydration were the most common reasons for unplanned readmission following TORS." | 1.46 | Unplanned readmission following transoral robotic surgery. ( Cognetti, DM; Curry, JM; Luginbuhl, A; Shumrick, C; Tassone, P; Topf, MC; Vo, A, 2017) |
| "Aspirin was continued in 25% of the cases." | 1.46 | Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy. ( Bensalah, K; Khene, Z; Mathieu, R; Peyronnet, B; Pradere, B; Roupret, M; Ruggiero, M; Seisen, T; Vaessen, C; Verhoest, G, 2017) |
| " The primary efficacy endpoint was major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, or stent thrombosis." | 1.43 | Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. ( Abizaid, A; Bhatt, DL; Chieffo, A; Colombo, A; Costa, RA; Feres, F; Genereux, P; Gilard, M; Giustino, G; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Leon, MB; Morice, MC; Palmerini, T; Park, KW; Redfors, B; Sardella, G; Sawaya, F; Stone, GW; Valgimigli, M, 2016) |
| "Six cases (6." | 1.43 | Complication of Stenting in Intracranial Arterial Stenosis. ( Liu, L; Zhang, F, 2016) |
| "Although frequent, hemoptysis is usually transient and minor." | 1.43 | Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy. ( Casutt, A; Koutsokera, A; Krueger, T; Lovis, A; Nicod, LP; Noetzli, J; Perentes, JY; Pons, M; Valenti, A, 2016) |
| "Despite recent advances in stent design and constantly improving protective pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI) are still major factors influencing morbidity and mortality." | 1.42 | Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up. ( Bulaeva, NI; Fortmann, S; Golukhova, EZ; Grigorian, MV; Ryabinina, MN; Serebruany, VL, 2015) |
| "Clopidogrel and ticlopidine, sometimes in combination with ASA, are associated with a low risk of bleeding during renal transplantation and does not seem to be a contraindication for renal transplant surgery." | 1.40 | Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. ( Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M, 2014) |
| "Unilateral vertebral artery dissection has been described in fewer than 40% of cases of RCVS." | 1.39 | Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. ( Do, HM; Mitchell, LA; Santarelli, JG; Singh, IP, 2013) |
| "Pocket hematoma is a troublesome complication associated with the implantation of cardiac implantable electronic devices (CIEDs)." | 1.39 | Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation. ( Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH, 2013) |
| "Onyx HD-500 is a liquid embolic used to treat intracranial aneurysms." | 1.39 | Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment. ( Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT, 2013) |
| "Aspirin was restarted on the first postoperative day and clopidogrel was restarted on the second postoperative day." | 1.38 | Perioperative management of a neurosurgical patient requiring antiplatelet therapy. ( Gregory Thompson, B; Rohatgi, P; Than, KD; Wilson, TJ, 2012) |
| "Stent thrombosis is not unusual in a post-operative setting." | 1.38 | Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis. ( Agnani, S; Akkus, NI; Rajpal, S, 2012) |
| "No choroidal or retrobulbar hemorrhages occurred in any patient." | 1.37 | Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. ( Albert, MA; Compton, CJ; Feist, RM; Frederick, PA; Gupta, SR; Heersink, MJ; Hill, ML; Mason, JO; Neimkin, MG; Thomley, ML; Vail, RS; White, MF, 2011) |
| "Only amlodipine was associated with clopidogrel poor-response." | 1.36 | The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. ( Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW, 2010) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 1.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| "Aspirin is an antiplatelet agent that acetylates cyclo-oxygenase and decreases the products of arachidonic acid metabolism, including thromboxane and prostacyclin." | 1.33 | Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats. ( Akan, M; Aköz, T; Cakir, B; Misirlioğlu, A; Taylan, G; Yildirim, S, 2005) |
| "Although saddle embolism is a relatively rare event, orthopaedic surgeons should be aware of this condition." | 1.33 | Saddle embolism after corrective femoral osteotomy: a case report. ( Hoshino, Y; Kariya, Y; Konishi, H; Noguchi, K; Ohashi, Y; Sekiya, H, 2006) |
| "Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease." | 1.31 | Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report. ( Buyukberber, S; Sari, R; Sevinc, A, 2000) |
| "Reduced anticoagulation with antiplatelet therapy alone after coronary stenting, despite infrequent use of intravascular ultrasound, is an effective and safe strategy with a low rate of vascular complications, a relatively short hospital stay and a low incidence of clinical manifestations of stent thrombosis." | 1.30 | Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice. ( Buller, CE; Chauhan, A; Moscovich, MD; Penn, IM; Ricci, DR; Zubaid, M, 1997) |
| "Hemorrhage was present in 9 cases of group B (21." | 1.30 | [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. ( Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ, 1997) |
| "Ticlopidine was withdrawn because of side effects in 11 patients." | 1.29 | [Treatment with ticlodipine after intracoronary stent implantation]. ( Golf, S; Myreng, Y; Mølstad, P, 1996) |
| "Ticlopidine appears to be an effective means of protecting graft patency as long as the biological effects of the drug are present." | 1.27 | Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. ( Chevigné, M; David, JL; Limet, R; Rigo, P, 1984) |
| "In 8 patients with liver cirrhosis who underwent hepatectomy, one patient with a prolonged T2 (260 secs) and a normal skin BT bled postoperatively, however, 3 patients with a prolonged skin BT (greater than 15 min) and a normal T2 had no hemorrhagic complications." | 1.27 | Clinical application of a new in vitro bleeding time device on surgical patients. ( Itoh, T; Kambayashi, J; Mori, T; Sakon, M; Tsujinaka, T; Uemura, Y, 1988) |
| " Nineteen out of them were treated with warfarin plus ticlopidine at a dosage enough to prolong the thrombo-test time to approximately 20% of normal value." | 1.27 | [Abnormalities of blood coagulation and effect of anticoagulant therapy in postoperative patients with lung cancer]. ( Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A; Tsurumi, T, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (6.07) | 18.7374 |
| 1990's | 28 (8.95) | 18.2507 |
| 2000's | 91 (29.07) | 29.6817 |
| 2010's | 173 (55.27) | 24.3611 |
| 2020's | 2 (0.64) | 2.80 |
| Authors | Studies |
|---|---|
| Tomaniak, M | 1 |
| Storey, RF | 1 |
| Serruys, PW | 1 |
| Ge, Z | 1 |
| Gao, XF | 1 |
| Kan, J | 1 |
| Kong, XQ | 1 |
| Zuo, GF | 1 |
| Ye, F | 1 |
| Tian, NL | 1 |
| Lin, S | 1 |
| Liu, ZZ | 1 |
| Shao, YB | 1 |
| He, YQ | 1 |
| Wen, SY | 1 |
| Yang, Q | 1 |
| Xia, Y | 1 |
| Wang, ZZ | 1 |
| Xiao, PX | 1 |
| Li, F | 1 |
| Zeng, HS | 1 |
| Yang, S | 1 |
| Wang, Y | 2 |
| Tao, L | 1 |
| Gao, DS | 1 |
| Qu, H | 1 |
| Qian, XS | 1 |
| Han, YL | 1 |
| Chen, F | 1 |
| Zhang, JJ | 1 |
| Chen, SL | 1 |
| Wu, X | 1 |
| Liu, G | 1 |
| Lu, J | 1 |
| Zheng, XX | 1 |
| Cui, JG | 1 |
| Zhao, XY | 1 |
| Huang, XH | 1 |
| Benedetto, U | 1 |
| Altman, DG | 1 |
| Gerry, S | 1 |
| Gray, A | 1 |
| Lees, B | 1 |
| Flather, M | 1 |
| Taggart, DP | 1 |
| Hansson, EC | 1 |
| Jeppsson, A | 1 |
| Abnousi, F | 1 |
| Sundaram, V | 1 |
| Yong, CM | 1 |
| Prats, J | 2 |
| Deliargyris, EN | 2 |
| Stone, GW | 8 |
| Hamm, CW | 3 |
| Steg, PG | 2 |
| Gibson, CM | 3 |
| White, HD | 2 |
| Price, MJ | 4 |
| Généreux, P | 3 |
| Desai, M | 1 |
| Yang, L | 1 |
| Ding, VY | 1 |
| Harrington, RA | 2 |
| Bhatt, DL | 7 |
| Mahaffey, KW | 2 |
| Pailleret, C | 1 |
| Ait Hamou, Z | 1 |
| Rosencher, N | 1 |
| Samama, CM | 1 |
| Eyraud, V | 1 |
| Chilot, F | 1 |
| Baillard, C | 1 |
| Vaduganathan, M | 3 |
| Zhang, J | 1 |
| Chen, X | 1 |
| Wang, J | 1 |
| Liu, Z | 1 |
| Wang, X | 2 |
| Ren, J | 1 |
| Sun, T | 1 |
| Pearcy, C | 1 |
| Almahmoud, K | 1 |
| Jackson, T | 1 |
| Hartline, C | 1 |
| Cahill, A | 1 |
| Spence, L | 1 |
| Kim, D | 1 |
| Olatubosun, O | 1 |
| Todd, SR | 1 |
| Campion, EM | 1 |
| Burlew, CC | 1 |
| Regner, J | 1 |
| Frazee, R | 1 |
| Michaels, D | 1 |
| Dissanaike, S | 1 |
| Stewart, C | 1 |
| Foley, N | 1 |
| Nelson, P | 1 |
| Agrawal, V | 1 |
| Truitt, MS | 1 |
| Atay, SM | 1 |
| Correa, AM | 1 |
| Hofstetter, WL | 1 |
| Mehran, RJ | 1 |
| Rice, DC | 1 |
| Roth, JA | 1 |
| Sepesi, B | 1 |
| Swisher, SG | 1 |
| Vaporciyan, AA | 1 |
| Walsh, G | 1 |
| Antonoff, MB | 1 |
| Topf, MC | 1 |
| Vo, A | 1 |
| Tassone, P | 1 |
| Shumrick, C | 1 |
| Luginbuhl, A | 1 |
| Cognetti, DM | 1 |
| Curry, JM | 1 |
| Ozawa, T | 1 |
| Suda, M | 1 |
| Ikegami, R | 1 |
| Takano, T | 1 |
| Wakasugi, T | 1 |
| Yanagawa, T | 1 |
| Tanaka, K | 1 |
| Ozaki, K | 1 |
| Hirono, S | 1 |
| Minamino, T | 1 |
| Joo, HJ | 1 |
| Ahn, SG | 1 |
| Park, JH | 1 |
| Park, JY | 1 |
| Hong, SJ | 1 |
| Kim, SY | 1 |
| Choi, W | 1 |
| Gwon, H | 1 |
| Lim, YH | 1 |
| Kim, W | 1 |
| Kang, WC | 1 |
| Cho, YH | 1 |
| Kim, YH | 1 |
| Yoon, J | 1 |
| Shin, W | 1 |
| Hong, MK | 2 |
| Garg, S | 1 |
| Jang, Y | 3 |
| Lim, DS | 1 |
| Consolo, F | 1 |
| Pozzi, L | 1 |
| Sferrazza, G | 1 |
| Della Valle, P | 1 |
| D'Angelo, A | 1 |
| Slepian, MJ | 1 |
| Pappalardo, F | 1 |
| Velibey, Y | 1 |
| Tekkeşin, Aİ | 1 |
| Barutca, H | 1 |
| Yıldırımtürk, Ö | 1 |
| Bozbeyoğlu, E | 1 |
| Çakıllı, Y | 1 |
| Güzelburç, Ö | 1 |
| Bora Şişman, S | 1 |
| Çinier, G | 1 |
| Şahin, S | 1 |
| Alper, AT | 1 |
| Wernly, B | 1 |
| Lichtenauer, M | 1 |
| Hoppe, UC | 1 |
| Lauten, A | 1 |
| Navarese, EP | 1 |
| Jung, C | 2 |
| Toba, T | 1 |
| Shinke, T | 1 |
| Otake, H | 1 |
| Sugizaki, Y | 1 |
| Takeshige, R | 1 |
| Onishi, H | 1 |
| Nagasawa, A | 1 |
| Tsukiyama, Y | 1 |
| Yanaka, K | 1 |
| Nagano, Y | 1 |
| Yamamoto, H | 1 |
| Kawamori, H | 1 |
| Matsuura, A | 1 |
| Ishihara, T | 1 |
| Matsumoto, D | 1 |
| Igarashi, N | 1 |
| Hayashi, T | 1 |
| Yasaka, Y | 1 |
| Kadotani, M | 1 |
| Fujii, T | 1 |
| Shite, J | 1 |
| Okada, M | 1 |
| Sakakibara, T | 1 |
| Hirata, KI | 1 |
| Lynch, DR | 1 |
| Dantzler, D | 1 |
| Robbins, M | 1 |
| Zhao, D | 1 |
| Chen, HC | 1 |
| Chen, YL | 1 |
| Guo, BF | 1 |
| Tsai, TH | 1 |
| Chang, JP | 1 |
| Pan, KL | 1 |
| Lin, YS | 1 |
| Chen, MC | 1 |
| Deo, SV | 1 |
| Dunlay, SM | 1 |
| Shah, IK | 1 |
| Altarabsheh, SE | 1 |
| Erwin, PJ | 1 |
| Boilson, BA | 1 |
| Park, SJ | 1 |
| Joyce, LD | 1 |
| Thapar, A | 1 |
| Jenkins, IH | 1 |
| Mehta, A | 1 |
| Davies, AH | 1 |
| Golan, S | 1 |
| Levkovitch-Verbin, H | 1 |
| Shemesh, G | 1 |
| Kurtz, S | 1 |
| Hossain, FS | 1 |
| Rambani, R | 1 |
| Ribee, H | 1 |
| Koch, L | 1 |
| McKenzie, JL | 1 |
| Douglas, G | 1 |
| Bazargan, A | 1 |
| Tanrıkulu, A | 1 |
| Ağırbaşlı, M | 1 |
| Lamberts, M | 1 |
| Gislason, GH | 1 |
| Olesen, JB | 1 |
| Kristensen, SL | 1 |
| Schjerning Olsen, AM | 1 |
| Mikkelsen, A | 1 |
| Christensen, CB | 1 |
| Lip, GY | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Hansen, ML | 1 |
| López, J | 1 |
| Morales, C | 1 |
| Avanzas, P | 1 |
| Callejo, F | 1 |
| Hernández-Vaquero, D | 1 |
| Llosa, JC | 1 |
| Preidl, RH | 1 |
| Eckl, S | 1 |
| Ramsperger-Gleixner, M | 1 |
| Koch, N | 1 |
| Spriewald, BM | 1 |
| Weyand, M | 1 |
| Ensminger, SM | 1 |
| Díaz DE LA Llera, LS | 1 |
| Cubero Gómez, JM | 1 |
| Rangel, D | 1 |
| Parejo, J | 1 |
| Acosta, J | 1 |
| Fernández-Cisnal, A | 1 |
| Zafra, F | 1 |
| Benezet, J | 1 |
| Callender, R | 1 |
| Altamirano, A | 1 |
| Tezino, T | 1 |
| Pivalizza, EG | 1 |
| Cattano, D | 1 |
| Müller, KA | 1 |
| Karathanos, A | 1 |
| Tavlaki, E | 1 |
| Stimpfle, F | 1 |
| Meissner, M | 1 |
| Bigalke, B | 1 |
| Stellos, K | 1 |
| Schwab, M | 1 |
| Schaeffeler, E | 1 |
| Müller, II | 1 |
| Gawaz, M | 1 |
| Geisler, T | 1 |
| Campo, G | 2 |
| Tebaldi, M | 3 |
| Vranckx, P | 2 |
| Biscaglia, S | 1 |
| Tumscitz, C | 1 |
| Ferrari, R | 1 |
| Valgimigli, M | 7 |
| Desai, NR | 1 |
| Canestaro, WJ | 1 |
| Kyrychenko, P | 1 |
| Chaplin, D | 1 |
| Martell, LA | 1 |
| Brennan, T | 1 |
| Matlin, OS | 1 |
| Choudhry, NK | 1 |
| Benahmed, A | 1 |
| Kianda, M | 1 |
| Ghisdal, L | 1 |
| Broeders, N | 1 |
| Massart, A | 1 |
| Lemy, A | 1 |
| Mikhalski, D | 1 |
| Hoang, AD | 1 |
| Donckier, V | 1 |
| Sadis, C | 1 |
| Le Moine, A | 1 |
| Madhoun, P | 1 |
| Racapé, J | 1 |
| Wissing, M | 1 |
| Abramowicz, D | 1 |
| Ariyaratnam, P | 1 |
| McLean, LA | 1 |
| Kotidis, K | 1 |
| Loubani, M | 1 |
| Miceli, A | 2 |
| Angelini, GD | 2 |
| Rubino, AS | 1 |
| Della Corte, A | 1 |
| Giordano, R | 1 |
| Menicanti, L | 1 |
| Gasparovic, H | 1 |
| Petricevic, M | 2 |
| Kopjar, T | 1 |
| Djuric, Z | 1 |
| Svetina, L | 2 |
| Biocina, B | 2 |
| Murray, AM | 1 |
| Keville, N | 1 |
| Gray, S | 1 |
| Kashiwazaki, D | 1 |
| Kuwayama, N | 1 |
| Akioka, N | 1 |
| Hayakawa, Y | 1 |
| Kuroda, S | 1 |
| Olivier, CB | 1 |
| Schnabel, K | 1 |
| Brandt, C | 1 |
| Weik, P | 1 |
| Olschewski, M | 2 |
| Zhou, Q | 1 |
| Bode, C | 1 |
| Diehl, P | 1 |
| Moser, M | 1 |
| Parekh, P | 1 |
| Agrawal, N | 1 |
| Vasavada, A | 1 |
| Vinchurkar, M | 1 |
| Kasivisvanathan, R | 1 |
| Abbassi-Ghadi, N | 1 |
| Kumar, S | 1 |
| Mackenzie, H | 1 |
| Thompson, K | 1 |
| James, K | 1 |
| Mallett, SV | 1 |
| Bagai, A | 1 |
| Wang, TY | 1 |
| Curtis, JP | 1 |
| Gurm, HS | 1 |
| Shah, B | 1 |
| Cheema, AN | 1 |
| Peterson, ED | 2 |
| Saucedo, JF | 1 |
| Granger, CB | 1 |
| Roe, MT | 1 |
| McNamara, RL | 1 |
| Alexander, KP | 1 |
| Daels, FP | 1 |
| Gaizauskas, A | 1 |
| Rioja, J | 1 |
| Varshney, AK | 1 |
| Erkan, E | 1 |
| Ozgok, Y | 1 |
| Melekos, M | 1 |
| de la Rosette, JJ | 1 |
| Une, D | 1 |
| Al-Atassi, T | 1 |
| Kulik, A | 2 |
| Voisine, P | 1 |
| Le May, M | 1 |
| Ruel, M | 2 |
| Hess, CN | 1 |
| Lopes, RD | 2 |
| Hager, R | 1 |
| Wojdyla, DM | 1 |
| Englum, BR | 1 |
| Mack, MJ | 1 |
| Califf, RM | 1 |
| Kouchoukos, NT | 1 |
| Alexander, JH | 2 |
| Patel, PA | 1 |
| Fleisher, LA | 1 |
| Pinnarelli, L | 1 |
| Mayer, F | 1 |
| Bauleo, L | 1 |
| Agabiti, N | 1 |
| Kirchmayer, U | 1 |
| Belleudi, V | 1 |
| Di Martino, M | 1 |
| Autore, C | 1 |
| Ricci, R | 1 |
| Violini, R | 1 |
| Fusco, D | 1 |
| Davoli, M | 1 |
| Perucci, CA | 1 |
| Isshiki, T | 2 |
| Kimura, T | 1 |
| Ogawa, H | 1 |
| Yokoi, H | 1 |
| Nanto, S | 1 |
| Takayama, M | 1 |
| Kitagawa, K | 1 |
| Nishikawa, M | 1 |
| Miyazaki, S | 1 |
| Ikeda, Y | 1 |
| Nakamura, M | 1 |
| Saito, S | 1 |
| Anderson, K | 1 |
| Jupiter, DC | 1 |
| Abernathy, SW | 1 |
| Frazee, RC | 1 |
| Gilard, M | 2 |
| Barragan, P | 3 |
| Noryani, AAL | 1 |
| Noor, HA | 1 |
| Majwal, T | 1 |
| Hovasse, T | 1 |
| Castellant, P | 1 |
| Schneeberger, M | 1 |
| Maillard, L | 1 |
| Bressolette, E | 1 |
| Wojcik, J | 1 |
| Delarche, N | 1 |
| Blanchard, D | 1 |
| Jouve, B | 1 |
| Ormezzano, O | 1 |
| Paganelli, F | 3 |
| Levy, G | 1 |
| Sainsous, J | 2 |
| Carrie, D | 1 |
| Furber, A | 1 |
| Berland, J | 1 |
| Darremont, O | 1 |
| Le Breton, H | 1 |
| Lyuycx-Bore, A | 1 |
| Gommeaux, A | 1 |
| Cassat, C | 1 |
| Kermarrec, A | 1 |
| Cazaux, P | 1 |
| Druelles, P | 1 |
| Dauphin, R | 1 |
| Armengaud, J | 1 |
| Dupouy, P | 1 |
| Champagnac, D | 1 |
| Ohlmann, P | 1 |
| Endresen, K | 1 |
| Benamer, H | 1 |
| Kiss, RG | 1 |
| Ungi, I | 2 |
| Boschat, J | 1 |
| Morice, MC | 4 |
| Garg, P | 1 |
| Galper, BZ | 1 |
| Cohen, DJ | 1 |
| Yeh, RW | 1 |
| Mauri, L | 2 |
| Patialiakas, A | 1 |
| Thury, A | 1 |
| McFadden, E | 1 |
| Colangelo, S | 1 |
| Tondi, S | 1 |
| Roffi, M | 1 |
| Menozzi, A | 1 |
| de Cesare, N | 1 |
| Garbo, R | 1 |
| Meliga, E | 2 |
| Testa, L | 2 |
| Gabriel, HM | 1 |
| Airoldi, F | 2 |
| Ferlini, M | 1 |
| Liistro, F | 1 |
| Dellavalle, A | 2 |
| Briguori, C | 1 |
| Kandzari, DE | 1 |
| Rosencher, J | 1 |
| Gouffran, G | 1 |
| Bougouin, W | 1 |
| Varenne, O | 1 |
| Gandhi, S | 1 |
| Schwalm, JD | 1 |
| Velianou, JL | 1 |
| Natarajan, MK | 1 |
| Farkouh, ME | 2 |
| Ginsel, BL | 1 |
| Taher, A | 1 |
| Whitehouse, SL | 1 |
| Bell, JJ | 1 |
| Pulle, CR | 1 |
| Crawford, RW | 1 |
| Shubert, D | 1 |
| Bono, J | 1 |
| Nandi, S | 1 |
| Yudi, MB | 1 |
| Eccleston, D | 1 |
| Andrianopoulos, N | 1 |
| Farouque, O | 1 |
| Duffy, SJ | 1 |
| Brennan, A | 1 |
| Reid, C | 1 |
| Clark, DJ | 1 |
| Ajani, AE | 1 |
| Madhavan, MV | 1 |
| Kirtane, AJ | 5 |
| Xu, K | 3 |
| Witzenbichler, B | 4 |
| Mehran, R | 5 |
| Ong, WL | 1 |
| Koh, TL | 1 |
| Fletcher, J | 1 |
| Gruen, R | 1 |
| Royce, P | 1 |
| Capranzano, P | 1 |
| Castiglioni, B | 1 |
| Siasos, G | 1 |
| Oikonomou, E | 1 |
| Zaromitidou, M | 1 |
| Kioufis, S | 1 |
| Kokkou, E | 1 |
| Mourouzis, K | 1 |
| Vlasis, K | 1 |
| Vavuranakis, M | 1 |
| Stone, PH | 1 |
| Papavassiliou, AG | 1 |
| Tousoulis, D | 1 |
| Pottegård, A | 1 |
| García Rodríguez, LA | 1 |
| Poulsen, FR | 1 |
| Hallas, J | 1 |
| Gaist, D | 1 |
| Golukhova, EZ | 1 |
| Grigorian, MV | 1 |
| Ryabinina, MN | 1 |
| Bulaeva, NI | 1 |
| Fortmann, S | 1 |
| Serebruany, VL | 1 |
| Wong, P | 1 |
| Tesoro, E | 1 |
| Aletich, V | 1 |
| Alaraj, A | 2 |
| Brodie, BR | 3 |
| Garg, A | 1 |
| Stuckey, TD | 3 |
| Maehara, A | 3 |
| Weisz, G | 3 |
| Rinaldi, MJ | 3 |
| Neumann, FJ | 5 |
| Metzger, DC | 3 |
| Parvataneni, R | 3 |
| Smilowitz, NR | 3 |
| Henry, TD | 2 |
| Cox, DA | 2 |
| Duffy, PL | 2 |
| Mazzaferri, EL | 2 |
| Yahagi, K | 1 |
| Virmani, R | 1 |
| Kesavamoorthy, B | 1 |
| Kim, JY | 1 |
| Choi, YS | 1 |
| Kwon, A | 1 |
| Chung, WB | 1 |
| Park, CS | 1 |
| Kim, HY | 1 |
| Chang, K | 1 |
| Lee, MY | 1 |
| Chung, WS | 1 |
| Seung, KB | 1 |
| Yang, H | 1 |
| Li, Y | 1 |
| Jiang, Y | 1 |
| Hunter, JB | 1 |
| Carlson, ML | 1 |
| Sweeney, AD | 1 |
| Tombers, NM | 1 |
| Wanna, GB | 1 |
| Driscoll, CL | 1 |
| Haynes, DS | 1 |
| Zhu, K | 1 |
| Fu, Q | 1 |
| Zhang, N | 1 |
| Huang, YJ | 1 |
| Zhang, Q | 1 |
| Valenti, A | 1 |
| Casutt, A | 1 |
| Koutsokera, A | 1 |
| Noetzli, J | 1 |
| Perentes, JY | 1 |
| Krueger, T | 1 |
| Pons, M | 1 |
| Nicod, LP | 1 |
| Lovis, A | 1 |
| Purushothaman, B | 1 |
| Webb, M | 1 |
| Weusten, A | 1 |
| Bonczek, S | 1 |
| Ramaskandhan, J | 1 |
| Nanu, A | 1 |
| Wąsowicz, M | 1 |
| Syed, S | 1 |
| Wijeysundera, DN | 1 |
| Starzyk, Ł | 1 |
| Grewal, D | 1 |
| Ragoonanan, T | 1 |
| Harsha, P | 1 |
| Travis, G | 1 |
| Carroll, J | 1 |
| Karkouti, K | 1 |
| Beattie, WS | 1 |
| Nijenhuis, VJ | 1 |
| Bennaghmouch, N | 1 |
| Hassell, M | 1 |
| Baan, J | 1 |
| van Kuijk, JP | 2 |
| Agostoni, P | 2 |
| van 't Hof, A | 1 |
| Kievit, PC | 1 |
| Veenstra, L | 1 |
| van der Harst, P | 1 |
| van den Heuvel, AF | 1 |
| den Heijer, P | 1 |
| Kelder, JC | 3 |
| Deneer, VH | 3 |
| van der Kley, F | 1 |
| Onorati, F | 1 |
| Collet, JP | 4 |
| Maisano, F | 1 |
| Latib, A | 2 |
| Huber, K | 2 |
| Stella, PR | 1 |
| Ten Berg, JM | 4 |
| Pacheco, C | 1 |
| Aguilar, M | 1 |
| Potter, BJ | 1 |
| Watanabe, Y | 1 |
| Kozuma, K | 1 |
| Ishikawa, S | 1 |
| Hosogoe, N | 1 |
| Berger, JS | 1 |
| Hummel, T | 1 |
| Meves, SH | 1 |
| Rüdiger, K | 1 |
| Mügge, A | 1 |
| Mumme, A | 1 |
| Burkert, B | 1 |
| Mühlberger, D | 1 |
| Neubauer, H | 1 |
| Oltmann, SC | 1 |
| Alhefdhi, AY | 1 |
| Rajaei, MH | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Chen, H | 1 |
| Chandrasekhar, J | 1 |
| Baber, U | 1 |
| Sartori, S | 1 |
| Faggioni, M | 1 |
| Aquino, M | 1 |
| Kini, A | 1 |
| Weintraub, W | 1 |
| Rao, S | 1 |
| Kapadia, S | 1 |
| Weiss, S | 1 |
| Strauss, C | 1 |
| Toma, C | 1 |
| Muhlestein, B | 1 |
| DeFranco, A | 1 |
| Effron, M | 1 |
| Keller, S | 1 |
| Baker, B | 1 |
| Pocock, S | 1 |
| Henry, T | 1 |
| Zhang, F | 1 |
| Liu, L | 1 |
| Dadjou, Y | 1 |
| Safavi, S | 1 |
| Kojuri, J | 1 |
| Morici, N | 1 |
| Perna, E | 1 |
| Cipriani, M | 1 |
| Femia, EA | 1 |
| Oliva, F | 1 |
| Frigerio, M | 1 |
| Cattaneo, M | 1 |
| Kayan, Y | 1 |
| Delgado Almandoz, JE | 1 |
| Fease, JL | 1 |
| Milner, AM | 1 |
| Scholz, JM | 1 |
| Mulder, M | 1 |
| Westerman, ME | 1 |
| Sharma, V | 1 |
| Scales, J | 1 |
| Gearman, DJ | 1 |
| Ingimarsson, JP | 1 |
| Krambeck, AE | 1 |
| Essandoh, MK | 1 |
| Dalia, AA | 1 |
| George, BS | 1 |
| Flores, AS | 1 |
| Otey, AJ | 1 |
| Broderick, TM | 1 |
| Rao, SV | 1 |
| Prates, PR | 1 |
| Williams, JB | 1 |
| Mehta, RH | 1 |
| Stevens, SR | 1 |
| Thomas, L | 1 |
| Smith, PK | 1 |
| Newby, LK | 1 |
| Kalil, RA | 1 |
| Giustino, G | 1 |
| Chieffo, A | 2 |
| Palmerini, T | 1 |
| Feres, F | 1 |
| Abizaid, A | 1 |
| Costa, RA | 1 |
| Kim, BK | 1 |
| Kim, HS | 3 |
| Park, KW | 2 |
| Sawaya, F | 1 |
| Sardella, G | 1 |
| Redfors, B | 1 |
| Leon, MB | 2 |
| Colombo, A | 6 |
| Pradere, B | 1 |
| Peyronnet, B | 1 |
| Seisen, T | 1 |
| Khene, Z | 1 |
| Ruggiero, M | 1 |
| Vaessen, C | 1 |
| Verhoest, G | 1 |
| Mathieu, R | 1 |
| Roupret, M | 1 |
| Bensalah, K | 1 |
| Sedat, J | 1 |
| Chau, Y | 1 |
| Gaudart, J | 1 |
| Sachet, M | 1 |
| Beuil, S | 1 |
| Lonjon, M | 1 |
| Fichter, AM | 1 |
| Ritschl, LM | 1 |
| Robitzky, LK | 1 |
| Wagenpfeil, S | 1 |
| Mitchell, DA | 1 |
| Wolff, KD | 1 |
| Mücke, T | 1 |
| Nairooz, R | 1 |
| Rochlani, Y | 1 |
| Pothineni, NV | 1 |
| Raina, S | 1 |
| Sardar, P | 1 |
| Mukherjee, D | 1 |
| Naidu, SS | 1 |
| Shavelle, DM | 1 |
| Piccolo, R | 1 |
| Magnani, G | 1 |
| Ariotti, S | 1 |
| Gargiulo, G | 1 |
| Marino, M | 1 |
| Santucci, A | 1 |
| Franzone, A | 1 |
| Heg, D | 1 |
| Windecker, S | 1 |
| van Diepen, S | 1 |
| Fuster, V | 1 |
| Verma, S | 1 |
| Hamza, TH | 1 |
| Siami, FS | 1 |
| Goodman, SG | 1 |
| Saydam, F | 1 |
| Değirmenci, İ | 1 |
| Birdane, A | 1 |
| Özdemir, M | 1 |
| Ulus, T | 1 |
| Özbayer, C | 1 |
| Çolak, E | 1 |
| Ata, N | 1 |
| Güneş, HV | 1 |
| Hudec, V | 1 |
| Bena, M | 1 |
| Artemiou, P | 1 |
| Gasparovic, I | 1 |
| Hulman, M | 1 |
| Nakagawa, I | 2 |
| Park, HS | 1 |
| Wada, T | 1 |
| Yokoyama, S | 1 |
| Yamada, S | 1 |
| Motoyama, Y | 1 |
| Kichikawa, K | 1 |
| Nakase, H | 1 |
| Shim, CY | 1 |
| Yoon, SJ | 1 |
| Park, S | 1 |
| Kim, JS | 2 |
| Choi, JR | 1 |
| Ko, YG | 1 |
| Choi, D | 1 |
| Ha, JW | 1 |
| Chung, N | 1 |
| Shim, WH | 1 |
| Cho, SY | 1 |
| Johansen, A | 1 |
| White, J | 1 |
| Turk, A | 2 |
| Barthwal, R | 1 |
| Herman, BA | 1 |
| Patel, RA | 1 |
| White, CJ | 1 |
| Gumina, RJ | 1 |
| Yang, EH | 1 |
| Sandhu, GS | 1 |
| Prasad, A | 1 |
| Bresnahan, JF | 1 |
| Lennon, RJ | 1 |
| Rihal, CS | 1 |
| Holmes, DR | 2 |
| Singh, M | 1 |
| McKellar, SH | 1 |
| Thompson, JL | 1 |
| Garcia-Rinaldi, RF | 1 |
| Macdonald, RJ | 1 |
| Sundt, TM | 1 |
| Schaff, HV | 1 |
| Alfonso, F | 1 |
| Pérez-Vizcayno, MJ | 1 |
| Hernández, R | 1 |
| Bethencourt, A | 1 |
| Martí, V | 1 |
| López-Mínguez, JR | 1 |
| Angel, J | 1 |
| Iñiguez, A | 1 |
| Morís, C | 1 |
| Cequier, A | 1 |
| Sabaté, M | 1 |
| Escaned, J | 1 |
| Jiménez-Quevedo, P | 1 |
| Bañuelos, C | 1 |
| Suárez, A | 1 |
| Macaya, C | 1 |
| Demaret, C | 1 |
| Crousier, M | 1 |
| Hanss, M | 1 |
| Ffrench, P | 1 |
| Piriou, V | 1 |
| de Miguel Castro, A | 1 |
| Cuellas Ramón, C | 1 |
| Diego Nieto, A | 1 |
| Samaniego Lampón, B | 1 |
| Alonso Rodríguez, D | 1 |
| Fernández Vázquez, F | 1 |
| Alonso Orcajo, N | 1 |
| Carbonell de Blas, R | 1 |
| Pascual Vicente, C | 1 |
| Pérez de Prado, A | 1 |
| Chan, V | 1 |
| Argüello Viudez, L | 1 |
| Rogacka, R | 1 |
| Michev, I | 1 |
| Cosgrave, J | 1 |
| Montorfano, M | 1 |
| Carlino, M | 1 |
| Sangiorgi, GM | 1 |
| Castelli, A | 1 |
| Godino, C | 1 |
| Magni, V | 1 |
| Aranzulla, TC | 1 |
| Romagnoli, E | 1 |
| Pecot, CV | 1 |
| Fuller, M | 1 |
| Muldowney, JA | 1 |
| Misra, S | 1 |
| Ruthmann, O | 1 |
| Seitz, A | 1 |
| Richter, S | 1 |
| Marjanovic, G | 1 |
| Hopt, UT | 1 |
| Fischer, A | 1 |
| Schrag, HJ | 1 |
| Gao, C | 1 |
| Ren, C | 1 |
| Li, D | 1 |
| Li, L | 1 |
| Natarajan, SK | 1 |
| Snyder, KV | 1 |
| Siddiqui, AH | 1 |
| Ionita, CC | 1 |
| Hopkins, LN | 1 |
| Levy, EI | 1 |
| Tetik, S | 1 |
| Ak, K | 1 |
| Isbir, S | 1 |
| Eksioglu-Demiralp, E | 1 |
| Arsan, S | 1 |
| Iqbal, O | 1 |
| Yardimci, T | 1 |
| Motovska, Z | 1 |
| Widimsky, P | 1 |
| Bae, JP | 1 |
| Dobesh, PP | 1 |
| McCollam, PL | 1 |
| Khoynezhad, A | 1 |
| Chatterjee, T | 1 |
| Akin, I | 1 |
| Rehders, TC | 1 |
| Chatterjee, A | 1 |
| Schüpfer, C | 1 |
| Nienaber, CA | 1 |
| Ince, H | 1 |
| Kim, DH | 1 |
| Daskalakis, C | 1 |
| Silvestry, SC | 1 |
| Sheth, MP | 1 |
| Lee, AN | 1 |
| Adams, S | 1 |
| Hohmann, S | 1 |
| Medvedev, S | 1 |
| Whellan, DJ | 1 |
| Sielski, J | 1 |
| Wałek, P | 1 |
| Polewczyk, A | 1 |
| Janion, M | 1 |
| Nesher, N | 1 |
| Singh, SK | 1 |
| Fawzy, HF | 1 |
| Sever, JY | 1 |
| Goldman, BE | 1 |
| Cohen, GN | 1 |
| Laflamme, C | 1 |
| Fremes, SE | 1 |
| Wait, SD | 1 |
| Abla, AA | 1 |
| Killory, BD | 1 |
| Starke, RM | 1 |
| Spetzler, RF | 1 |
| Nakaji, P | 1 |
| Kramer, E | 1 |
| Hadad, E | 1 |
| Westreich, M | 1 |
| Shalom, A | 1 |
| Breet, NJ | 3 |
| van Werkum, JW | 2 |
| Bouman, HJ | 1 |
| Ruven, HJ | 2 |
| Bal, ET | 1 |
| Harmsze, AM | 2 |
| van der Heyden, JA | 1 |
| Rensing, BJ | 1 |
| Suttorp, MJ | 1 |
| Hackeng, CM | 2 |
| Osta, WA | 1 |
| Akbary, H | 1 |
| Fuleihan, SF | 1 |
| Doraiswamy, VA | 1 |
| García-Bracamonte, B | 1 |
| Vanaclocha, F | 1 |
| Robijns, K | 1 |
| Klungel, OH | 1 |
| de Boer, A | 1 |
| Ho, PM | 1 |
| Tsai, TT | 1 |
| Maddox, TM | 1 |
| Powers, JD | 1 |
| Carroll, NM | 1 |
| Jackevicius, C | 1 |
| Go, AS | 1 |
| Margolis, KL | 1 |
| DeFor, TA | 1 |
| Rumsfeld, JS | 1 |
| Magid, DJ | 1 |
| Anselmino, M | 1 |
| Moretti, C | 2 |
| Ravera, L | 1 |
| Sheiban, I | 2 |
| Sharpe, RY | 1 |
| Dennis, MJ | 1 |
| Nasim, A | 1 |
| McCarthy, MJ | 1 |
| Sayers, RD | 1 |
| London, NJ | 2 |
| Naylor, AR | 3 |
| Nydick, JA | 1 |
| Farrell, ED | 1 |
| Marcantonio, AJ | 1 |
| Hume, EL | 1 |
| Marburger, R | 1 |
| Ostrum, RF | 1 |
| Möllmann, H | 1 |
| Nef, HM | 1 |
| Kalyanasundaram, A | 1 |
| Berger, PB | 3 |
| Hodgson, RE | 1 |
| Miller, SM | 1 |
| Fortuna, A | 1 |
| Harrison, GR | 1 |
| Bellemain-Appaix, A | 1 |
| Brieger, D | 1 |
| Beygui, F | 2 |
| Silvain, J | 1 |
| Pena, A | 1 |
| Cayla, G | 1 |
| Barthélémy, O | 1 |
| Montalescot, G | 3 |
| Gandhi, NK | 1 |
| Abdel-Karim, AR | 1 |
| Banerjee, S | 1 |
| Brilakis, ES | 1 |
| Voute, MT | 1 |
| Flu, WJ | 1 |
| Schouten, O | 1 |
| Chonchol, M | 1 |
| Hoeks, SE | 1 |
| Boersma, EE | 1 |
| Verhagen, HJ | 1 |
| Bax, JJ | 1 |
| Poldermans, D | 1 |
| Kang, HS | 1 |
| Han, MH | 1 |
| Kwon, BJ | 1 |
| Kim, JE | 1 |
| Kwon, OK | 1 |
| Oh, CW | 1 |
| Mason, JO | 1 |
| Gupta, SR | 1 |
| Compton, CJ | 1 |
| Frederick, PA | 1 |
| Neimkin, MG | 1 |
| Hill, ML | 1 |
| Heersink, MJ | 1 |
| Vail, RS | 1 |
| White, MF | 1 |
| Feist, RM | 1 |
| Thomley, ML | 1 |
| Albert, MA | 1 |
| Fernández-Sender, L | 1 |
| Martínez-Cerezo, FJ | 1 |
| Amorós, S | 1 |
| Tena, FJ | 1 |
| Marsal, J | 1 |
| Pascual, D | 1 |
| Suh, JW | 1 |
| Lee, SP | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Koo, BK | 1 |
| Cho, YS | 1 |
| Youn, TJ | 1 |
| Chae, IH | 1 |
| Choi, DJ | 1 |
| Rha, SW | 1 |
| Bae, JH | 1 |
| Kwon, TG | 1 |
| Bae, JW | 1 |
| Cho, MC | 1 |
| Bonatti, J | 1 |
| Zimrin, D | 1 |
| Suissa, S | 1 |
| Savage, EB | 1 |
| Geara, AS | 1 |
| Ayoub, I | 1 |
| Abi Rached, J | 1 |
| Siddique, MN | 1 |
| Ghimire, P | 1 |
| El-Sayegh, S | 1 |
| Klisch, J | 1 |
| Turner, R | 1 |
| Woo, HH | 1 |
| Fiorella, D | 1 |
| Morofuji, Y | 1 |
| So, G | 1 |
| Hiu, T | 1 |
| Kawakubo, J | 1 |
| Hayashi, K | 1 |
| Kitagawa, N | 1 |
| Morikawa, M | 1 |
| Suyama, K | 1 |
| Nagata, I | 1 |
| Cook-Norris, RH | 1 |
| Michaels, JD | 1 |
| Weaver, AL | 1 |
| Phillips, PK | 1 |
| Brewer, JD | 1 |
| Roenigk, RK | 1 |
| Otley, CC | 1 |
| Fernando, H | 1 |
| Dart, AM | 1 |
| Peter, K | 1 |
| Shaw, JA | 1 |
| Satler, LF | 1 |
| Nijjer, SS | 1 |
| Watson, G | 1 |
| Athanasiou, T | 1 |
| Malik, IS | 1 |
| Barequet, IS | 1 |
| Sachs, D | 1 |
| Shenkman, B | 1 |
| Priel, A | 1 |
| Wasserzug, Y | 1 |
| Budnik, I | 1 |
| Moisseiev, J | 1 |
| Salomon, O | 1 |
| Bordeaux, JS | 1 |
| Martires, KJ | 1 |
| Goldberg, D | 1 |
| Pattee, SF | 1 |
| Fu, P | 1 |
| Maloney, ME | 1 |
| Duggie, AJ | 1 |
| Dimech, J | 1 |
| Brown, JS | 1 |
| Mahmoud, TH | 1 |
| Nwachuku, IC | 1 |
| Jones, M | 1 |
| Clough, TM | 1 |
| Cardona, L | 1 |
| Ana, G | 1 |
| Luísa, B | 1 |
| Leal, A | 1 |
| António, F | 1 |
| Lídia, S | 1 |
| Cruz, FR | 1 |
| Mascarenhas, L | 1 |
| Brar, SS | 1 |
| ten Berg, J | 1 |
| Marcucci, R | 1 |
| Patti, G | 2 |
| DiSciascio, G | 1 |
| Cuisset, T | 2 |
| Dangas, G | 2 |
| Wiviott, SD | 1 |
| Hochholzer, W | 1 |
| Parrett, BM | 1 |
| Woo, A | 1 |
| Buntic, R | 1 |
| Singer, M | 1 |
| Brizzio, ME | 1 |
| Shaw, RE | 1 |
| Bosticco, B | 1 |
| Collins, M | 2 |
| Grau, JB | 1 |
| Mak, AW | 1 |
| Zapolanski, A | 1 |
| Akkus, NI | 1 |
| Rajpal, S | 1 |
| Agnani, S | 1 |
| Malik, AI | 1 |
| Foster, RE | 1 |
| Correa, ZM | 1 |
| Petersen, MR | 1 |
| Miller, DM | 1 |
| Riemann, CD | 1 |
| Jaitner, J | 1 |
| Morath, T | 1 |
| Byrne, RA | 1 |
| Braun, S | 1 |
| Gebhard, D | 1 |
| Bernlochner, I | 1 |
| Schulz, S | 1 |
| Mehilli, J | 1 |
| Schömig, A | 4 |
| Koch, W | 1 |
| Kastrati, A | 3 |
| Sibbing, D | 1 |
| Furlan, AJ | 1 |
| Reisman, M | 1 |
| Massaro, J | 1 |
| Adams, H | 1 |
| Albers, GW | 1 |
| Felberg, R | 1 |
| Herrmann, H | 1 |
| Kar, S | 1 |
| Landzberg, M | 1 |
| Raizner, A | 1 |
| Wechsler, L | 1 |
| Kiviniemi, T | 1 |
| Karjalainen, P | 1 |
| Pietilä, M | 1 |
| Ylitalo, A | 1 |
| Niemelä, M | 1 |
| Vikman, S | 1 |
| Puurunen, M | 1 |
| Biancari, F | 1 |
| Airaksinen, KE | 1 |
| Bonello, L | 2 |
| Berbis, J | 1 |
| Laine, M | 1 |
| Armero, S | 1 |
| Bessereau, J | 2 |
| Jacquin, L | 1 |
| Bonello, C | 1 |
| Camillieri, E | 1 |
| Dignat-George, F | 1 |
| Camoin-Jau, L | 2 |
| Kizilkilic, O | 1 |
| Kocer, N | 1 |
| Metaxas, GE | 1 |
| Babic, D | 1 |
| Homan, R | 1 |
| Islak, C | 1 |
| Uhry, S | 1 |
| Al Khudairy, A | 1 |
| Al-Mallah, JM | 1 |
| Al-Hadeedi, O | 1 |
| Sayana, MK | 1 |
| Mrdovic, I | 1 |
| Savic, L | 1 |
| Krljanac, G | 1 |
| Asanin, M | 1 |
| Perunicic, J | 1 |
| Antonijevic, N | 1 |
| Lasica, R | 1 |
| Marinkovic, J | 1 |
| Kocev, N | 1 |
| Vasiljevic, Z | 1 |
| Mahla, E | 1 |
| Höchtl, T | 1 |
| Prüller, F | 1 |
| Freynhofer, MK | 1 |
| Mangiacapra, F | 1 |
| Barbato, E | 1 |
| Orlic, D | 1 |
| Peace, AJ | 1 |
| D'Ambrosio, A | 1 |
| Ostojic, M | 1 |
| Wijns, W | 1 |
| Di Sciascio, G | 2 |
| Duggan, SM | 1 |
| Aresu, G | 1 |
| de Siena, PM | 1 |
| Romeo, F | 1 |
| Glauber, M | 1 |
| Caputo, M | 1 |
| Than, KD | 1 |
| Rohatgi, P | 1 |
| Wilson, TJ | 1 |
| Gregory Thompson, B | 1 |
| Del Pozo, M | 1 |
| Martí, J | 1 |
| Guirado, L | 1 |
| Facundo, C | 1 |
| Canal, C | 1 |
| de la Torre, P | 1 |
| Ballarín, J | 1 |
| Díaz, JM | 1 |
| Fujikawa, T | 1 |
| Maekawa, H | 1 |
| Shiraishi, K | 1 |
| Tanaka, A | 1 |
| Sadanandan, S | 1 |
| Singh, IM | 1 |
| Bötticher, G | 1 |
| Gäbel, G | 1 |
| Weiss, N | 1 |
| Saeger, HD | 1 |
| Bergert, H | 1 |
| Liang, GZ | 1 |
| Zhang, FX | 1 |
| Luo, XY | 1 |
| Zhang, CM | 1 |
| Hu, L | 1 |
| Feng, YP | 1 |
| Niu, LY | 1 |
| Zhang, H | 1 |
| Ma, BB | 1 |
| Qi, HS | 1 |
| Guo, MM | 1 |
| Long, YY | 1 |
| Li, HL | 1 |
| Milicic, D | 1 |
| Carlson, AP | 1 |
| Amin-Hanjani, S | 1 |
| Charbel, FT | 1 |
| Aletich, VA | 1 |
| Riml, S | 1 |
| Wallner, H | 1 |
| Kompatscher, P | 1 |
| Mitchell, LA | 1 |
| Santarelli, JG | 1 |
| Singh, IP | 1 |
| Do, HM | 1 |
| Turpie, AG | 1 |
| Hiller, E | 1 |
| Timperley, J | 1 |
| Clarke, NR | 1 |
| Banning, AP | 1 |
| Kim, MH | 1 |
| Cha, KS | 1 |
| Han, JY | 1 |
| Kim, HJ | 1 |
| Alam, M | 1 |
| Goldberg, LH | 1 |
| Mueller, C | 1 |
| Roskamm, H | 2 |
| Hunziker, P | 1 |
| Marsch, S | 1 |
| Perruchoud, A | 1 |
| Buettner, HJ | 1 |
| Rott, D | 1 |
| Jessup, DB | 1 |
| Coletti, AT | 1 |
| Muhlestein, JB | 1 |
| Barry, WH | 1 |
| Shean, FC | 1 |
| Whisenant, BK | 1 |
| Baralis, G | 1 |
| Steffenino, G | 1 |
| La Scala, E | 1 |
| Uslenghi, E | 1 |
| Hui, AJ | 1 |
| Wong, RM | 1 |
| Ching, JY | 1 |
| Hung, LC | 1 |
| Chung, SC | 1 |
| Sung, JJ | 1 |
| Moses, JW | 2 |
| Ludwig, J | 1 |
| Spanos, V | 1 |
| Louvard, Y | 1 |
| Desmedt, B | 1 |
| Di Mario, C | 2 |
| Payne, DA | 2 |
| Jones, CI | 2 |
| Hayes, PD | 2 |
| Thompson, MM | 1 |
| Bell, PR | 1 |
| Goodall, AH | 2 |
| Schömig, E | 1 |
| Ferguson, JJ | 1 |
| van der Heijden, DJ | 1 |
| Westendorp, IC | 1 |
| Riezebos, RK | 1 |
| Kiemeneij, F | 1 |
| Slagboom, T | 1 |
| van der Wieken, LR | 1 |
| Laarman, GJ | 1 |
| Stadius, ML | 1 |
| Casselman, FP | 1 |
| Meco, M | 1 |
| Dom, H | 1 |
| Foubert, L | 1 |
| Van Praet, F | 1 |
| Vanermen, H | 1 |
| Ernst, NM | 1 |
| Suryapranata, H | 1 |
| Miedema, K | 1 |
| Slingerland, RJ | 1 |
| Ottervanger, JP | 1 |
| Hoorntje, JC | 1 |
| Gosselink, AT | 1 |
| Dambrink, JH | 1 |
| de Boer, MJ | 1 |
| Zijlstra, F | 1 |
| van 't Hof, AW | 1 |
| Klima, U | 1 |
| MacVaugh, H | 1 |
| Bagaev, E | 1 |
| Maringka, M | 1 |
| Kirschner, S | 1 |
| Beilner, J | 1 |
| Haverich, A | 1 |
| Sharma, SK | 1 |
| Choudhury, A | 1 |
| Lee, J | 1 |
| Kim, MC | 1 |
| Fisher, E | 1 |
| Steinheimer, AM | 1 |
| Kini, AS | 1 |
| Chu, MW | 1 |
| Wilson, SR | 1 |
| Novick, RJ | 1 |
| Stitt, LW | 1 |
| Quantz, MA | 1 |
| Kapetanakis, EI | 1 |
| Medlam, DA | 1 |
| Boyce, SW | 1 |
| Haile, E | 1 |
| Hill, PC | 1 |
| Dullum, MK | 1 |
| Bafi, AS | 1 |
| Petro, KR | 1 |
| Corso, PJ | 1 |
| Bavry, AA | 1 |
| Kumbhani, DJ | 1 |
| Helton, TJ | 1 |
| Akan, M | 1 |
| Cakir, B | 1 |
| Misirlioğlu, A | 1 |
| Yildirim, S | 1 |
| Taylan, G | 1 |
| Aköz, T | 1 |
| Gurbel, PA | 1 |
| Bliden, KP | 1 |
| Hayes, KM | 1 |
| Yoho, JA | 1 |
| Herzog, WR | 1 |
| Tantry, US | 1 |
| Wood, F | 1 |
| Bazemore, E | 1 |
| Schneider, JE | 1 |
| Jobe, RL | 1 |
| Mann, T | 1 |
| Gluckman, TJ | 1 |
| Rade, JJ | 1 |
| Schulman, SP | 1 |
| Sharifi, M | 1 |
| Dehghani, M | 1 |
| Mehdipour, M | 1 |
| Al-Bustami, O | 1 |
| Emrani, F | 1 |
| Burks, J | 1 |
| Cay, S | 1 |
| Yilmaz, MB | 1 |
| Korkmaz, S | 1 |
| Wilmshurst, PT | 1 |
| Nightingale, S | 1 |
| Walsh, KP | 1 |
| Morrison, WL | 1 |
| Eriksson, P | 1 |
| Wanke, I | 1 |
| Doerfler, A | 1 |
| Goericke, S | 1 |
| Gizewski, ER | 1 |
| Sandalcioglu, E | 1 |
| Moemken, S | 1 |
| Stolke, D | 1 |
| Forsting, M | 1 |
| Hitos, K | 1 |
| Fletcher, JP | 1 |
| García-Rinaldi, R | 1 |
| Steinhubl, SR | 2 |
| Brennan, DM | 1 |
| Topol, EJ | 3 |
| Klutmann, M | 1 |
| Tillmanns, C | 1 |
| Gulba, DC | 1 |
| Le Feuvre, C | 1 |
| Batisse, A | 1 |
| Batisse, JP | 1 |
| Choussat, R | 1 |
| Helft, G | 1 |
| Metzger, JP | 1 |
| Sekiya, H | 1 |
| Noguchi, K | 1 |
| Ohashi, Y | 1 |
| Kariya, Y | 1 |
| Hoshino, Y | 1 |
| Konishi, H | 1 |
| Potapov, EV | 1 |
| Hetzer, R | 1 |
| Collins, P | 1 |
| Ford, I | 1 |
| Greaves, M | 1 |
| Macaulay, E | 1 |
| Brittenden, J | 1 |
| McAllister, RK | 1 |
| Dehmer, GJ | 1 |
| Meyer, TA | 1 |
| Digne, F | 1 |
| Gérardin, B | 1 |
| Pillière, R | 1 |
| Estagnasié, P | 1 |
| Dib, JC | 1 |
| Terdjman, M | 1 |
| Grinda, JM | 1 |
| Dubois, C | 1 |
| Tomita, H | 1 |
| Hatakeyama, K | 1 |
| Soda, W | 1 |
| Kobayashi, T | 1 |
| Ziegelin, M | 1 |
| Hoschtitzky, A | 1 |
| Dunning, J | 1 |
| Hooper, T | 1 |
| Spiess, BD | 1 |
| van der Linden, J | 1 |
| Augoustides, JG | 1 |
| Lotrionte, M | 1 |
| Biondi-Zoccai, GG | 1 |
| Abbate, A | 1 |
| Angiolillo, DJ | 1 |
| Alessi, MC | 1 |
| Waksman, R | 1 |
| Sangiorgi, G | 1 |
| Laudito, A | 1 |
| Trevi, GP | 1 |
| Lavelle, WF | 1 |
| Demers Lavelle, EA | 1 |
| Uhl, R | 1 |
| Sokurenko, GIu | 1 |
| Luk'ianov, IuV | 1 |
| Parusova, EV | 1 |
| Edovina, LN | 1 |
| Limet, R | 2 |
| David, JL | 2 |
| Rigo, P | 2 |
| Lapeyrère, X | 1 |
| Gruyer, P | 1 |
| Guyot, L | 1 |
| Barbe, G | 1 |
| Saint-Paul, B | 1 |
| Chevigné, M | 1 |
| Mayumi, T | 1 |
| Dohi, S | 1 |
| Davies, JA | 1 |
| Tindall, H | 1 |
| Paton, RC | 1 |
| Menys, VC | 1 |
| Doig, RL | 1 |
| Kester, RC | 1 |
| McNicol, GP | 1 |
| Brommer, EJ | 1 |
| Renner, C | 1 |
| Guilmet, D | 1 |
| Curtet, JM | 1 |
| Van Belle, E | 1 |
| McFadden, EP | 1 |
| Lablanche, JM | 1 |
| Bauters, C | 1 |
| Hamon, M | 1 |
| Bertrand, ME | 1 |
| Schühlen, H | 2 |
| Blasini, R | 1 |
| Hadamitzky, M | 2 |
| Walter, H | 2 |
| Zitzmann-Roth, EM | 1 |
| Richardt, G | 1 |
| Alt, E | 1 |
| Schmitt, C | 1 |
| Ulm, K | 2 |
| Lo, CY | 1 |
| Cheng, IK | 1 |
| Tso, WK | 1 |
| Mak, KO | 1 |
| Myreng, Y | 1 |
| Mølstad, P | 1 |
| Golf, S | 1 |
| Goods, CM | 1 |
| al-Shaibi, KF | 1 |
| Liu, MW | 1 |
| Yadav, JS | 1 |
| Mathur, A | 1 |
| Jain, SP | 1 |
| Dean, LS | 1 |
| Iyer, SS | 1 |
| Parks, JM | 1 |
| Roubin, GS | 1 |
| Pan, M | 1 |
| Suárez de Lezo, J | 1 |
| Velasco, F | 1 |
| Romero, M | 1 |
| Medina, A | 1 |
| Segura, J | 1 |
| Hernández, E | 1 |
| Pavlovic, D | 1 |
| Melian, F | 1 |
| Gallardo, A | 1 |
| Zayas, R | 1 |
| Ruiz, M | 1 |
| Torres, A | 1 |
| Albiero, R | 1 |
| Hall, P | 1 |
| Itoh, A | 1 |
| Blengino, S | 1 |
| Nakamura, S | 1 |
| Martini, G | 1 |
| Ferraro, M | 2 |
| Zubaid, M | 1 |
| Penn, IM | 1 |
| Buller, CE | 1 |
| Moscovich, MD | 1 |
| Ricci, DR | 1 |
| Chauhan, A | 1 |
| Silvestri, M | 1 |
| Simeoni, JB | 1 |
| Bayet, G | 1 |
| Roquebert, PO | 1 |
| Bouvier, JL | 1 |
| Comet, B | 1 |
| Quatre, JM | 1 |
| Linnemeier, TJ | 1 |
| Reimers, B | 1 |
| Reinhardt, R | 1 |
| Moussa, I | 2 |
| Iturbe, T | 1 |
| Sánchez, C | 1 |
| Moreno, JA | 1 |
| Olave, T | 1 |
| Azaceta, G | 1 |
| Varo, MJ | 1 |
| Civeira, E | 1 |
| Peleato, J | 1 |
| Cornudella, R | 1 |
| Feldman, TE | 1 |
| Oemrawsingh, PV | 2 |
| Tuinenburg, JC | 1 |
| Schalij, MJ | 2 |
| Jukema, JW | 1 |
| Reiber, JH | 1 |
| Bruschke, AV | 2 |
| Udayachalerm, W | 1 |
| van der Wall, EE | 1 |
| Alvarez, JM | 1 |
| Harper, RW | 1 |
| Peverill, RE | 1 |
| Madan, M | 1 |
| Marquis, JF | 1 |
| de May, MR | 1 |
| Laramee, LA | 1 |
| Leddy, D | 1 |
| O'Brien, E | 1 |
| Williams, WL | 1 |
| Higginson, LA | 1 |
| Jelley, J | 1 |
| Reid, F | 1 |
| Johansen, H | 1 |
| Labinaz, M | 1 |
| Zidar, JP | 1 |
| Aramendi, JL | 1 |
| Agredo, J | 1 |
| Llorente, A | 1 |
| Larrarte, C | 1 |
| Pijoan, J | 1 |
| Reffelmann, T | 1 |
| vom Dahl, J | 1 |
| Hendriks, F | 1 |
| Klues, HG | 1 |
| Hanrath, P | 1 |
| Oetgen, M | 1 |
| Roubin, G | 1 |
| Iyer, S | 1 |
| Maida, R | 1 |
| Kreps, E | 1 |
| Bennett, CL | 1 |
| Davidson, CJ | 1 |
| Green, D | 1 |
| Weinberg, PD | 1 |
| Feldman, MD | 1 |
| McCullough, PA | 1 |
| Marks, KR | 1 |
| Jafary, FH | 1 |
| Kimmelstiel, CD | 1 |
| Müller, C | 1 |
| Büttner, HJ | 1 |
| Petersen, J | 1 |
| Miller, JL | 1 |
| Van Langenhove, G | 1 |
| Vermeersch, P | 1 |
| Serrano, P | 1 |
| Kutryk, MJ | 1 |
| Stockman, D | 1 |
| Convens, C | 1 |
| Van den Branden, F | 1 |
| Vanagt, E | 1 |
| Albertal, M | 1 |
| Van den Heuvel, P | 1 |
| Kobza, II | 1 |
| Sannes, MR | 1 |
| Modi, KS | 1 |
| Sari, R | 1 |
| Sevinc, A | 1 |
| Buyukberber, S | 1 |
| Kleiman, NS | 1 |
| Grazeiadei, N | 1 |
| Maresh, K | 1 |
| Taylor, RJ | 1 |
| Frederick, B | 1 |
| Lance, ET | 1 |
| Effron, MB | 1 |
| Jordan, RE | 1 |
| Mascelli, MA | 1 |
| Calver, AL | 1 |
| Blows, LJ | 1 |
| Harmer, S | 1 |
| Dawkins, KD | 1 |
| Gray, HH | 1 |
| Morgan, JH | 1 |
| Simpson, IA | 1 |
| Chew, DP | 1 |
| Hirsch, AT | 1 |
| Ringleb, PA | 1 |
| Hacke, W | 1 |
| Ellis, SG | 1 |
| Wolski, K | 1 |
| Lincoff, AM | 1 |
| Hutten, BA | 1 |
| Verheugt, FW | 1 |
| Plokker, HW | 1 |
| Tanabe, Y | 1 |
| Ito, E | 1 |
| Suzuki, K | 1 |
| Griffo, R | 1 |
| De Servi, S | 1 |
| Yende, S | 1 |
| D'Ancona, G | 1 |
| Donias, HW | 1 |
| Karamanoukian, RL | 1 |
| Bergsland, J | 1 |
| Karamanoukian, HL | 1 |
| Bartorelli, AL | 1 |
| Trabattoni, D | 1 |
| Montorsi, P | 1 |
| Fabbiocchi, F | 1 |
| Galli, S | 1 |
| Ravagnani, P | 1 |
| Grancini, L | 1 |
| Cozzi, S | 1 |
| Loaldi, A | 1 |
| Vera, M | 1 |
| Pou, M | 1 |
| Botey, A | 1 |
| Cases, A | 1 |
| Saitoh, H | 2 |
| Matsumoto, H | 1 |
| Takayama, T | 2 |
| Ide, H | 1 |
| Miyawaki, F | 1 |
| Furuse, A | 1 |
| Tsujinaka, T | 1 |
| Itoh, T | 1 |
| Uemura, Y | 1 |
| Sakon, M | 1 |
| Kambayashi, J | 1 |
| Mori, T | 1 |
| Shiguma, S | 1 |
| Tachibana, S | 1 |
| Asada, K | 1 |
| Ohzeki, M | 1 |
| Sasaki, S | 1 |
| Takeuchi, A | 1 |
| Ogawa, J | 1 |
| Tsurumi, T | 1 |
| Inoue, H | 2 |
| Koide, S | 1 |
| Kawada, S | 1 |
| Shohtsu, A | 1 |
| Binaghi, F | 1 |
| Fronteddu, PF | 1 |
| Cannas, F | 1 |
| Martelli, V | 1 |
| Kudo, T | 1 |
| Shimizu, T | 1 |
| Kawachi, K | 1 |
| Konagai, N | 1 |
| Hino, H | 1 |
| Furukawa, K | 1 |
| Harker, LA | 1 |
| Rothlin, ME | 1 |
| Pfluger, N | 1 |
| Speiser, K | 1 |
| Goebel, N | 1 |
| Krayenbühl, HP | 1 |
| Steinbrunn, W | 1 |
| Turina, M | 1 |
| Senning, A | 1 |
| Gröntoft, KC | 1 |
| Mulec, H | 1 |
| Gutierrez, A | 1 |
| Olander, R | 1 |
| Criado, A | 1 |
| Juffé, A | 1 |
| Carmona, J | 1 |
| Otero, C | 1 |
| Avello, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents Guided by Either Intravascular Ultrasound or Angiography in Patients With Acute Coronary Syndrome: The Prospective, Multicenter, Randomized, Placebo-[NCT03971500] | 3,710 participants (Actual) | Interventional | 2019-08-20 | Active, not recruiting | |||
| Analysis of the Platelet Activity State in Patients Implanted With Ventricular Assist Device (VAD)[NCT03255928] | 60 participants (Anticipated) | Observational [Patient Registry] | 2017-06-29 | Recruiting | |||
| PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY[NCT00611286] | Phase 4 | 1,700 participants (Anticipated) | Interventional | 2006-12-31 | Completed | ||
| Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting[NCT01159639] | Phase 4 | 200 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm[NCT02527044] | 120 participants (Anticipated) | Interventional | 2015-11-30 | Active, not recruiting | |||
| Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423] | Phase 2 | 113 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures[NCT00042081] | Phase 3 | 3,000 participants | Interventional | 2002-07-31 | Completed | ||
| Is There A LIfe for DES After Discontinuation of Clopidogrel:The ITALIC PLUS Trial[NCT01476020] | 1,240 participants (Anticipated) | Observational | 2011-11-30 | Not yet recruiting | |||
| Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study[NCT01385319] | Phase 3 | 1,606 participants (Actual) | Interventional | 2011-06-30 | Active, not recruiting | ||
| CAOCT Study is a Prospective, Multi-centre, Single Cohort, Diagnostic Accuracy Study, Planned to Include 131 Patients in About 3 European Countries After Successful Return of Spontaneous Circulation After Out of Hospital Cardiac Arrest[NCT04431661] | 28 participants (Actual) | Observational | 2021-01-29 | Terminated (stopped due to Low patient recruitment rate and change of hopsital procedures for handling cardiac arrest patients during emergency) | |||
| Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents[NCT00638794] | 8,575 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| Dual Arm Factorial Randomized Trial in Patients w/ST Segment Elevation AMI to Compare the Results of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; and Primary An[NCT00433966] | Phase 3 | 3,602 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery[NCT01707459] | 201 participants (Actual) | Observational | 2010-03-31 | Completed | |||
| Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation[NCT02247128] | Phase 4 | 1,016 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events[NCT05733208] | 766 participants (Anticipated) | Interventional | 2023-05-06 | Recruiting | |||
| Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study[NCT04852406] | 526 participants (Anticipated) | Interventional | 2021-04-21 | Recruiting | |||
| Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)[NCT00086450] | Phase 3 | 1,900 participants (Actual) | Interventional | 2004-04-30 | Active, not recruiting | ||
| Prospective Study of Bioresorbable Vascular Scaffold Treatment With Scoring Balloon Pre-dilatation in Patients With In-stent Restenosis[NCT03069066] | Phase 4 | 100 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | ||
| RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial[NCT01239953] | Phase 4 | 190 participants (Actual) | Interventional | 2010-01-31 | Active, not recruiting | ||
| RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial[NCT01239940] | Phase 4 | 310 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | ||
| Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis[NCT02672878] | Phase 4 | 130 participants (Anticipated) | Interventional | 2014-04-30 | Not yet recruiting | ||
| Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis[NCT03167424] | 100 participants (Anticipated) | Observational [Patient Registry] | 2016-05-31 | Recruiting | |||
| Do Point-of-care Platelet Function Assays Predict Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI. (The POPular Study)[NCT00352014] | 1,000 participants (Anticipated) | Observational | 2006-01-31 | Completed | |||
| Effect of Low Dose of Colchicine on Platelet Reactivty in Patients With Chronic Coronary Disease[NCT05956145] | Phase 3 | 80 participants (Anticipated) | Interventional | 2021-06-17 | Recruiting | ||
| Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374] | Phase 4 | 300 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention[NCT03114995] | Phase 4 | 140 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| Influence of CILostazol-based Triple Anti-platelet Therapy ON Ischemic Complication After Drug-eluting stenT Implantation[NCT00776828] | Phase 4 | 960 participants (Actual) | Interventional | 2006-11-30 | Completed | ||
| A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention[NCT03378934] | Phase 4 | 64 participants (Anticipated) | Interventional | 2018-09-26 | Recruiting | ||
| A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism [NCT00201461] | Phase 2/Phase 3 | 900 participants (Anticipated) | Interventional | 2003-06-30 | Active, not recruiting | ||
| Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding.[NCT02875353] | 235 participants (Anticipated) | Interventional | 2017-02-15 | Recruiting | |||
| SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT00697372] | Phase 4 | 150 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| Prospective Randomized Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions / BABILON Study (Paclitaxel-Coated Balloon in Bifurcated Lesions)[NCT01278186] | Phase 4 | 190 participants (Anticipated) | Interventional | 2010-06-30 | Active, not recruiting | ||
| Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions[NCT00288535] | Phase 4 | 200 participants (Anticipated) | Interventional | 2005-03-31 | Recruiting | ||
| Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation[NCT00905671] | Phase 4 | 20 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT01200693] | Phase 4 | 80 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Approaches to Chronic Occlusions With Sirolimus Stents-Cypher (ACROSS-Cypher) Total Occlusion Study of Coronary Arteries 4 Trial[NCT00378612] | Phase 3 | 200 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery[NCT03445273] | 1,800 participants (Anticipated) | Observational [Patient Registry] | 2018-11-21 | Not yet recruiting | |||
| Non-randomized, Open-label, Historical Control, Single Group Assignment Trial of a Reduced Dose of Unfractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions[NCT00735280] | Phase 4 | 2,505 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting[NCT00776633] | Phase 4 | 614 participants (Actual) | Interventional | 2008-09-30 | Active, not recruiting | ||
| Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.[NCT00149591] | 300 participants | Interventional | 2001-04-30 | Active, not recruiting | |||
| A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percuta[NCT00271401] | Phase 3 | 2,399 participants (Actual) | Interventional | 1996-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 4 |
| Placebo | 5 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 1 |
| Placebo | 0 |
Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery
| Intervention | percentage (Number) |
|---|---|
| 75mg Clopidogrel | 94.3 |
| Placebo | 93.2 |
IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery
| Intervention | mm (Mean) |
|---|---|
| 75mg Clopidogrel | 4.1 |
| Placebo | 4.5 |
Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) (NCT00433966)
Timeframe: 3 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Pharmacology Arm - Bivalirudin | 379 |
| Pharmacology Arm - Unfractionated Heparin | 377 |
Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) (NCT00433966)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Pharmacology Arm - Bivalirudin | 98 |
| Pharmacology Arm - Unfractionated Heparin | 99 |
Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) and major bleeding (bleeding adjudicated as not related to coronary artery bypass grafting). (NCT00433966)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Pharmacology Arm - Bivalirudin | 166 |
| Pharmacology Arm - Unfractionated Heparin | 218 |
Number of participants with major bleeding (bleeding adjudicated as not related to coronary artery bypass grafting) (NCT00433966)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Pharmacology Arm - Bivalirudin | 89 |
| Pharmacology Arm - Unfractionated Heparin | 149 |
Number of Participants With Death, Reinfarction, Stroke, or Stent Thrombosis (NCT00433966)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Stent Arm - Paclitaxel-Eluting Stent | 181 |
| Stent Arm - Bare Metal Stent | 59 |
Number of Participants With Ischemic Target Lesion Revascularization (NCT00433966)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Stent Arm - Paclitaxel-Eluting Stent | 98 |
| Stent Arm - Bare Metal Stent | 54 |
Number of Participants With Segment Binary Angiographic Restenosis (13-month Angiographic Subset). (NCT00433966)
Timeframe: 13 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Stent Arm - Paclitaxel-Eluting Stent | 102 |
| Stent Arm - Bare Metal Stent | 76 |
median 3.8 years of follow-up (NCT00086450)
Timeframe: Measured at Year 5
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 26.6 |
| Coronary Artery Bypass Graft | 18.7 |
(NCT00086450)
Timeframe: Measured at Year 5
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 16.3 |
| Coronary Artery Bypass Graft | 10.9 |
(NCT00086450)
Timeframe: Measured at Year 1
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 16.8 |
| Coronary Artery Bypass Graft | 11.8 |
Major adverse cardiovascular and cerebrovascular events (NCT00086450)
Timeframe: Measured at Day 30
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 4.8 |
| Coronary Artery Bypass Graft | 5.2 |
An area under the curve of serial levels of Troponin I and creatine kinase-MB isoenzyme during 36 hours (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Hours*ng/ml (Median) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 38.0 | 92.7 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 121.4 | 185.6 |
| Group A (High Platelet Reactivity - Tirofiban) | 197.2 | 252.5 |
"Percentage of participants with periprocedural myonecrosis under the criteria described below.~When the cardiac biomarkers before the procedure were within the 99th percentile upper reference limit (URL), more than a 5-fold elevation in the URL within 12 hours after percutaneous coronary intervention (PCI) was defined as periprocedural myonecrosis. If the cardiac biomarker level was already above the 99th percentile URL before the procedure and the trend was stationary or decreasing, a ≥20% increase compared to the previous level was considered periprocedural myonecrosis. If the trend was still increasing, the levels at the post-6 hour and 12-hour were compared to determine periprocedural myonecrosis." (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 15 | 10 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 26 | 25 |
| Group A (High Platelet Reactivity - Tirofiban) | 16 | 11 |
32 reviews available for ticlopidine and Complication, Postoperative
| Article | Year |
|---|---|
Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients.
Topics: Aspirin; Blood Platelets; Cardiac Surgical Procedures; Hemorrhage; Humans; Platelet Aggregation Inhi | 2017 |
Triple therapy: worth the risk?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitor | 2018 |
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Fibrinolytic Agents; Heart Val | 2013 |
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occl | 2013 |
Diagnosis and management of carotid atherosclerosis.
Topics: Carotid Artery Diseases; Carotid Artery, Common; Clopidogrel; Endarterectomy, Carotid; Female; Human | 2013 |
Perioperative management of anticoagulation in elective surgery.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Di | 2013 |
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combi | 2013 |
Aspirin, clopidogrel, and the surgeon.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Humans; Platelet Aggregati | 2014 |
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Fem | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspi | 2016 |
Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy.
Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Percutaneous Coronary Intervention; Platelet Aggregati | 2017 |
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combinatio | 2009 |
Clopidogrel before elective percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Elective Surgical Procedures; | 2010 |
[Perioperative antiplatelet therapy of patients with coronary stents].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort S | 2009 |
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Postoperative Complica | 2010 |
Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Blood Vessel Prosthesis Implantation; Clopid | 2011 |
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies.
Topics: Acute Coronary Syndrome; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critical Care; Fema | 2011 |
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Inf | 2011 |
Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel | 2012 |
[Platelet function: new drugs, new assays : possible impacts on operative medicine?].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Piperazines; Platelet Aggregation; P | 2012 |
Clopidogrel: the data, the experience, and the controversies.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; H | 2012 |
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?].
Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relations | 2012 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A | 2002 |
[Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative | 2003 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost | 2005 |
[Very late intrastent thrombosis--at 27 months!].
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Fatal Outcome; Flurbiprofen; Follow-Up Studies; Hernia, I | 2007 |
Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicin | 2007 |
Con: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans | 2007 |
Pro: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhi | 2007 |
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedul | 2007 |
Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; | 2000 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
70 trials available for ticlopidine and Complication, Postoperative
| Article | Year |
|---|---|
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice
Topics: Acute Coronary Syndrome; Adult; Aspirin; Coronary Angiography; Drug-Eluting Stents; Dual Anti-Platel | 2021 |
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, D | 2017 |
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
Topics: Adenosine Monophosphate; Administration, Oral; Aged; Cause of Death; Clopidogrel; Coronary Angiograp | 2017 |
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).
Topics: Adenosine Monophosphate; Aged; Anticoagulants; Clopidogrel; Dose-Response Relationship, Drug; Double | 2017 |
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.
Topics: Aged; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Cytochrome | 2018 |
Anterior chamber bleeding after laser peripheral iridotomy.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; F | 2013 |
Combination of high on-treatment platelet aggregation and low deaggregation better predicts long-term cardiovascular events in PCI patients under dual antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Disease-Free Surviva | 2014 |
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Restenosis; Female; Humans; Italy; Male; Mid | 2014 |
Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Croatia; Dose-Response | 2014 |
A high ratio of ADP-TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone.
Topics: Adenosine Diphosphate; Aged; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Humans; Ma | 2014 |
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
Topics: Aged; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Gra | 2014 |
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP | 2014 |
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Elu | 2015 |
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
Topics: Aged; Aged, 80 and over; Aspirin; Biocompatible Materials; Clopidogrel; Coronary Angiography; Corona | 2015 |
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
Topics: Aged; Antithrombins; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combinati | 2017 |
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; | 2015 |
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
Topics: Aged; Blood Vessel Prosthesis Implantation; Clopidogrel; Drug Interactions; Drug-Eluting Stents; Fem | 2015 |
Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction.
Topics: Adenosine; Aged; Clopidogrel; Combined Modality Therapy; Drug Administration Schedule; Female; Human | 2015 |
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.
Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans; | 2016 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; | 2016 |
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi | 2016 |
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; | 2016 |
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Drug Therapy, Combination; Female | 2017 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati | 2017 |
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.
Topics: Aged; Cardiovascular Surgical Procedures; Clopidogrel; Drug Resistance; Drug Therapy, Combination; D | 2009 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; | 2008 |
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Re | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applyin
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Echocardiography, Stress; Humans; Myo | 2010 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Co | 2012 |
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Topics: Aged; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; P | 2013 |
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYo
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Dose-Response Relationship, Drug; Humans; International | 2012 |
Angioplasty and stent treatment of transplant renal artery stenosis.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Aspirin; Clopidogrel; Female; Follow-Up Studies; Humans; H | 2012 |
[A prospective randomized control clinical trial about clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after femoral-popliteal artery angioplasty].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Clopidogrel; Fema | 2012 |
Effect of antioxidant probucol for preventing stent restenosis.
Topics: Aged; Antioxidants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Ar | 2002 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Drug Ther | 2003 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endar | 2004 |
Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; | 2004 |
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Combined Modal | 2004 |
Magnetic Vascular Port in minimally invasive direct coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Angiography; Drug Therapy, Combination; Equipment | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost | 2005 |
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
Topics: Adenosine Diphosphate; Aged; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Femal | 2005 |
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Ischemia; | 2006 |
Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Contrast Media; Coronary Angio | 2006 |
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Body Weight; Clopidogrel; Endarterectomy, Carotid; | 2007 |
Ticlopidine and coronary surgery.
Topics: Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Humans; Post | 1984 |
The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.
Topics: Bleeding Time; Hemorrhage; Humans; Male; Platelet Function Tests; Postoperative Complications; Prost | 1981 |
[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Cardiac Surgical Procedures; Extracorporeal Circulation; | 1980 |
Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; | 1995 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy.
Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Eq | 1997 |
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISA
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Diseases; Combined Modality | 1997 |
PAMI (Primary Angioplasty in Myocardial Infarction) Stent Pilot Trial.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Drug Therapy, Combination; Follow-Up Studies; Humans; Myoca | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Low molecular weight heparin in coronary stenting.
Topics: Coronary Disease; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pilot Proj | 1998 |
Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
Topics: Aortic Valve; Bioprosthesis; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Huma | 1998 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; D | 1999 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Female | 2000 |
[The drug prevention of postoperative thromboses in patients with critical lower limb ischemia].
Topics: Anticoagulants; Aspirin; Critical Illness; Humans; Ischemia; Leg; Nadroparin; Platelet Aggregation I | 1999 |
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Thrombosis; Drug T | 2000 |
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Female; Hospitalization; Hum | 2001 |
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial.
Topics: Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Models, Statistical; Outcome and Process | 2001 |
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
Topics: Administration, Oral; Aneurysm, False; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cere | 2001 |
Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Carbon; Coa | 2002 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion.
Topics: Acenocoumarol; Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypas | 1985 |
Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.
Topics: Adult; Aged; Anticoagulants; Arteriovenous Shunt, Surgical; Clinical Trials as Topic; Double-Blind M | 1985 |
213 other studies available for ticlopidine and Complication, Postoperative
| Article | Year |
|---|---|
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?
Topics: Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibito | 2020 |
Administration of Ticagrelor and Double-Dose Clopidogrel Based on Platelet Reactivity Determined by VerifyNow-P2Y12 for Chinese Subjects After Elective PCI.
Topics: Adenosine; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutane | 2017 |
A retrospective comparison between delayed and early hip fracture surgery in patients taking clopidogrel: same total bleeding but different timing of blood transfusion.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Female; Fracture Fixation, Internal; Hemiar | 2017 |
Poor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort study.
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; China; Clopidogrel; Cohort S | 2017 |
Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy.
Topics: Adult; Appendectomy; Appendicitis; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Fe | 2017 |
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.
Topics: Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Huma | 2017 |
Unplanned readmission following transoral robotic surgery.
Topics: Carcinoma, Squamous Cell; Clopidogrel; Dehydration; Female; Humans; Male; Middle Aged; Mouth; Mouth | 2017 |
Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Dose-Response Relationshi | 2018 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist | 2018 |
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation.
Topics: Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Femal | 2018 |
Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
Topics: Aged; Aged, 80 and over; Aspirin; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug-Eluting St | 2019 |
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defib | 2013 |
Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Comorbidity; Databases, Factual; Female; He | 2013 |
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopido | 2013 |
Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Corona | 2013 |
Clopidogrel reduces post-transplant obliterative bronchiolitis.
Topics: Animals; Blood Platelets; Bronchiolitis Obliterans; Calcineurin Inhibitors; Clopidogrel; Cytokines; | 2013 |
A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching.
Topics: Angioplasty; Antithrombins; Clopidogrel; Cohort Studies; Drug Combinations; Female; Hirudins; Humans | 2013 |
Is it possible? Predicting complications and morbidity in surgical patients on clopidogrel therapy with Thrombelastography Platelet Mapping.
Topics: Female; Hemorrhage; Hip Fractures; Humans; Male; Postoperative Complications; Ticlopidine | 2014 |
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogre | 2013 |
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug; | 2014 |
Thromboelastography platelet mapping for surgical patients: lessons from cardiac surgery.
Topics: Female; Hemorrhage; Hip Fractures; Humans; Male; Postoperative Complications; Ticlopidine | 2014 |
Reply to Rubino et al.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2014 |
Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2014 |
A cautionary tale on the use of antiplatelet treatment following TURP.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myoca | 2014 |
The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neur | 2014 |
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Elu | 2014 |
Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery.
Topics: Aged; Case-Control Studies; Clopidogrel; Erythrocyte Transfusion; Female; Humans; Male; Middle Aged; | 2014 |
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
Topics: Acute Disease; Age Factors; Aged; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged; | 2014 |
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascula | 2015 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy.
Topics: Adult; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Female; Humans; Italy; Longitudinal Stud | 2015 |
Should clopidogrel be discontinued before laparoscopic cholecystectomy?
Topics: Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Cholecystectomy, Laparoscopic; Clopidogrel; Fe | 2014 |
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Decision Support Techniques; Drug-Eluting Stents; Fem | 2015 |
Stent selection and antiplatelet therapy duration: one size does not fit all.
Topics: Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage; | 2015 |
Optimal antiplatelet therapy in out-hospital cardiac arrest patients treated by primary percutaneous coronary intervention.
Topics: Female; Heart Arrest; Humans; Hypothermia, Induced; Male; Myocardial Infarction; Percutaneous Corona | 2015 |
Effects of anticoagulants on outcome of femoral neck fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Human | 2015 |
Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Clopidogre | 2015 |
Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Australia; Clopidogrel; Female; Hemorrhage; Humans; Logistic | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogre | 2015 |
[The ISAR-SAFE study].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Administr | 2015 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-4 | 2015 |
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrin | 2015 |
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Angiograp | 2015 |
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; | 2015 |
Revisiting the Clopidogrel-Proton Pump Inhibitor Interaction: From Bench to Bedside.
Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl | 2015 |
Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
Topics: Absorbable Implants; Adult; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Coronary Vessels | 2017 |
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Evero | 2015 |
Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
Topics: Adult; Aged; Aspirin; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Mid | 2016 |
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hem | 2016 |
Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.
Topics: Aspirin; Clopidogrel; Hemoptysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumo | 2016 |
Decision making on timing of surgery for hip fracture patients on clopidogrel.
Topics: Aged, 80 and over; Blood Transfusion; Clopidogrel; Contraindications; Decision Making; Female; Hemog | 2016 |
Letter by Pacheco et al Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".
Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl | 2016 |
Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".
Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl | 2016 |
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up S | 2016 |
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.
Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Hematoma; Humans; Male; Middle Aged; Parathyroidectomy | 2016 |
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Topics: Acute Coronary Syndrome; Age Factors; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Stud | 2017 |
Complication of Stenting in Intracranial Arterial Stenosis.
Topics: Age Factors; Aged; Angioplasty; Aspirin; China; Clopidogrel; Computed Tomography Angiography; Constr | 2016 |
Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution.
Topics: Adenosine; Aged; Aspirin; Blood Coagulation; Cardiomyopathies; Clopidogrel; Drug Substitution; Drug | 2016 |
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Cohort Studies; Elective Surgical Procedures; Endovascu | 2017 |
The Effect of Antiplatelet Agents on Bleeding-Related Complications After Ureteroscopy.
Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Hemorrhage; H | 2016 |
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopid | 2016 |
Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate.
Topics: Aspirin; Cardiopulmonary Bypass; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Fem | 2016 |
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle A | 2016 |
Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; | 2017 |
Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
Topics: Adult; Aged; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolizatio | 2017 |
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.
Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Graft Survival; Heparin; | 2016 |
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cause of Death; Clopidogrel; Diabetic Angiopathies; Drug The | 2017 |
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequenc | 2017 |
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Va | 2017 |
Clopidogrel therapy--implications for hip fracture surgery.
Topics: Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Drug Administration Schedule; Follow-Up Studie | 2008 |
Very late stent thrombosis after discontinuation of clopidogrel therapy.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studi | 2008 |
Survival benefit with concomitant oral platelet therapy after coronary angiography and before ad hoc percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography; | 2008 |
Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Confidence Intervals; | 2008 |
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Anim | 2008 |
[Management of a high risk of thrombosis patient with drug-eluting stents undergoing a complete gastrectomy].
Topics: Aged; Clopidogrel; Drug-Eluting Stents; Gastrectomy; Humans; Male; Monitoring, Physiologic; Platelet | 2009 |
Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronar | 2009 |
[Do antiplatelet agents (aspirin and other antiplatelets such as clopidogrel) increase the risk of hemorrhagic complications after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these pro
Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Hemorrhage; Humans; Platelet Aggregation Inhibito | 2009 |
Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosi | 2008 |
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusio | 2009 |
[Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopid | 2010 |
Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Cerebral Arteries; Clopidogrel; Fema | 2009 |
Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; American Heart Association; Blood Transfusion; Clopidogrel; Coronary | 2009 |
Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
Topics: Adult; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Female; Human | 2009 |
[Antiplatelet therapy and urgent surgical procedures. Acute appendicitis two days after stent implantation--a case report].
Topics: Appendicitis; Clopidogrel; Coronary Thrombosis; Dobutamine; Humans; Intraoperative Complications; Ma | 2009 |
Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.
Topics: Analysis of Variance; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Cor | 2010 |
Safety of carotid endarterectomy while on clopidogrel (Plavix). Clinical article.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Edema; E | 2010 |
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Aged; Analgesia, Epidural; Clopidogrel; Female; Hematoma, Epidural, Spinal; Humans; Male; Middle Age | 2010 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug | 2010 |
[Comment about patients with dual antiplatelet therapy].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Contraindications; Drug Therapy, Combina | 2010 |
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platel | 2010 |
I had two stents put in during the past year, but I'm going to have a hip replacement soon. Are there any heart-related or stent related precautions my doctor and I should take before the surgery?
Topics: Angioplasty, Balloon, Coronary; Arthroplasty, Replacement, Hip; Aspirin; Clopidogrel; Drug-Eluting S | 2009 |
Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.
Topics: Cardiovascular Diseases; Chemotherapy, Adjuvant; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up | 2010 |
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Chemical and Drug Induced Liver Injury; Clopidogr | 2010 |
Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
Topics: Aged; Angioscopy; Anticoagulants; Aspirin; Clopidogrel; Dextrans; Drug Therapy, Combination; Endarte | 2010 |
The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Contraindications; Femal | 2010 |
Clinical pharmacology: antiplatelet therapy during surgery.
Topics: Aspirin; Blood Loss, Surgical; Clopidogrel; Humans; Perioperative Care; Platelet Aggregation Inhibit | 2010 |
The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Atherectomy; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Diagnostic | 2010 |
Routine platelet testing should not be performed on all patients undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Atherectomy; Blood Platelets; Clopidogrel; Diagnostic Tests, Routine; Human | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitor | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitor | 2010 |
Frequency and risk of noncardiac surgery after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Drug-Eluting Stents; Fem | 2011 |
Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?
Topics: Aneurysm, Ruptured; Clopidogrel; Embolization, Therapeutic; Female; Humans; Incidence; Intracranial | 2010 |
Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
Topics: Aged; Anticoagulants; Cardiovascular Diseases; Choroid Hemorrhage; Clopidogrel; Humans; Incidence; I | 2011 |
Upper digestive bleeding due to Dieulafoy´s lesion during the postoperative period of aortocoronary bypass surgery in a patient treated with clopidogrel.
Topics: Aged; Arterioles; Clopidogrel; Coronary Artery Bypass; Gastrointestinal Hemorrhage; Humans; Male; Pl | 2010 |
Invited commentary.
Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Drainage; Humans; Intubation | 2011 |
Immortal person-time bias in observational studies in cardiac surgery.
Topics: Aspirin; Bias; Clopidogrel; Coronary Artery Bypass; Data Interpretation, Statistical; Drug Therapy, | 2011 |
Did clopidogrel confound the results?
Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Humans; Platelet Aggregation Inhibitors; Postoperativ | 2011 |
Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
Topics: Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Drug Resistance; Humans; Kidney Failur | 2011 |
Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms.
Topics: Adult; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Circulation; Clopidogrel; F | 2011 |
[Preoperative analysis of platelet aggregability in carotid surgery].
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Clopidogrel; Endarterectomy, Carotid; Female; Hu | 2011 |
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Fem | 2011 |
The impact of noncardiac surgery on selection of a revascularization strategy.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Drug-Eluting Stents; Humans; Myocardial Infarction; Pat | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, C | 2011 |
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.
Topics: Aged; Ambulatory Surgical Procedures; Antibiotic Prophylaxis; Anticoagulants; Clopidogrel; Dermatolo | 2011 |
Emergency surgery following trancutaneous aortic valve insertion.
Topics: Aged, 80 and over; Aortic Valve; Aspirin; Blood Loss, Surgical; Clopidogrel; Emergency Medical Servi | 2011 |
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperativ | 2011 |
Clopidogrel: is a surgical delay necessary in fractured neck of femur?
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Dipyridamole; Female; Femoral Neck Fract | 2011 |
Thrombus formation on a left atrial appendage closure device.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; | 2011 |
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hemat | 2012 |
On-clopidogrel platelet reactivity: a target in sight?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Platelet Activation; Platelet Agg | 2011 |
The safety of major head and neck surgery in patients taking clopidogrel (Plavix).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Thrombosis; Female; Head and Neck | 2012 |
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage.
Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion; Clopi | 2012 |
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Heparin; Humans; Intra-Aortic | 2012 |
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupi | 2012 |
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cas | 2012 |
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrilla | 2012 |
Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Animals; Clinical Protocols; Clopidog | 2012 |
Utility of VasoCT in the treatment of intracranial aneurysm with flow-diverter stents.
Topics: Adult; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Catheterization; Cereb | 2012 |
To the editor.
Topics: Female; Humans; Male; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complica | 2012 |
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting.
Topics: Aged; Aspirin; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Fema | 2013 |
Perioperative management of a neurosurgical patient requiring antiplatelet therapy.
Topics: Aged; Aspirin; Cerebral Angiography; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Thromb | 2012 |
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage; | 2012 |
Clopidogrel and aspirin administration management prior to coronary artery surgery requires an individual approach.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2013 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Patholog | 2013 |
Friend or foe? Discussion about dual platelet inhibition as a salvage procedure from imminent flap failure.
Topics: Aspirin; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mamma | 2013 |
Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section.
Topics: Aspirin; Cerebral Angiography; Cesarean Section; Clopidogrel; Female; Headache; Humans; Magnetic Res | 2013 |
[Long-term anticoagulation after bypass operation].
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhi | 2002 |
New antiplatelet agents and prosthetic heart valves.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Clopidogrel; Female; Heart Valve Prosthesis Implantation; H | 2002 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem | 2002 |
Clopidogrel versus ticlopidine after the placement of coronary artery stents.
Topics: Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans | 2003 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardia | 2003 |
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; | 2004 |
Are we making efficient use of clopidogrel?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhib | 2004 |
If there's smoke, is there fire?
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Endpoint Determination; Hu | 2004 |
Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coron | 2004 |
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Corona | 2004 |
Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Biomarkers; Blood Vessel Pr | 2004 |
Does clopidogrel increase blood loss following coronary artery bypass surgery?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critica | 2004 |
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Coronary Disease | 2005 |
Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Dose-Response Relationship, | 2005 |
Technique of left main stenting is dependent on lesion location and distal branch protection.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Mate | 2005 |
The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome.
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Admini | 2005 |
Intense migraines secondary to percutaneous closure of atrial septal defects.
Topics: Adult; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Female; Follow-Up St | 2005 |
Intracranial bleeding associated with clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Human | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa | 2005 |
Economic effects of extended clopidogrel therapy--a word of caution.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative | 2005 |
Treatment of wide-necked intracranial aneurysms with a self-expanding stent: mid-term results.
Topics: Aneurysm, Ruptured; Clopidogrel; Follow-Up Studies; Humans; Intracranial Aneurysm; Neurosurgical Pro | 2005 |
Venous thromboembolism and fractured neck of femur.
Topics: Aged; Aged, 80 and over; Anesthesia; Anticoagulants; Aspirin; Blood Loss, Surgical; Blood Transfusio | 2005 |
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Sel | 2006 |
[Postoperative antithrombotic treatment in diabetic patients].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mell | 2006 |
Saddle embolism after corrective femoral osteotomy: a case report.
Topics: Arterial Occlusive Diseases; Atrial Fibrillation; Echocardiography, Transesophageal; Embolectomy; Em | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposi | 2006 |
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation; | 2006 |
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents.
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Pa | 2006 |
Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
Topics: Adolescent; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Humans; Migraine with Aur | 2007 |
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Plat | 2007 |
Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus.
Topics: Adult; Clopidogrel; Emergency Treatment; Female; Fracture Fixation, Internal; Health Care Surveys; H | 2008 |
[Antithrombotic therapy in operations on extracranial arteries].
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Endarterectomy, Carotid; Female; Fibri | 2008 |
[Comparative action of different platelet anti-aggregants in the postoperative period].
Topics: Anticoagulants; Dipyridamole; Humans; Papaverine; Parasympatholytics; Platelet Aggregation; Postoper | 1984 |
Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study.
Topics: Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Po | 1984 |
Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
Topics: Aged; Anesthesia, Spinal; Anticoagulants; Female; Hematoma; Humans; Postoperative Complications; Spi | 1983 |
Platelet survival in patients treated with ticlopidine following reconstructive arterial surgery.
Topics: Aged; Aorta; Blood Platelets; Blood Vessel Prosthesis; Cell Survival; Dose-Response Relationship, Dr | 1982 |
Percutaneous transluminal angioplasty for transplant renal artery stenosis.
Topics: Adolescent; Adult; Angioplasty, Balloon; Female; Heparin; Humans; Kidney Transplantation; Male; Midd | 1996 |
[Treatment with ticlodipine after intracoronary stent implantation].
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet | 1996 |
Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting.
Topics: Aged; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Plate | 1996 |
Reduction of thrombotic and hemorrhagic complications after stent implantation.
Topics: Acute Disease; Aged; Anticoagulants; Coronary Angiography; Coronary Thrombosis; Female; Follow-Up St | 1996 |
Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Ar | 1997 |
Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coronary Angiography; Coronary Vessels; Female; Foll | 1997 |
Stenting without ASA?
Topics: Humans; Incidence; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications | 1997 |
New stent delivery balloon: a technical note.
Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Hu | 1997 |
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation | 1997 |
Revascularization after CABG: atherectomy and stenting.
Topics: Aftercare; Aged; Algorithms; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Bypass; Co | 1998 |
Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Vessel Prosthesis Implantation; Coro | 1998 |
Micro stent implantation in patients with acute myocardial infarction without anticoagulation: clinical experience with two different antithrombotic protocols.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiograp | 1998 |
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; | 1998 |
Coronary stenting in unstable angina: early and late clinical outcomes.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Disease; | 1998 |
Chronology of use of ticlopidine to prevent stent occlusion.
Topics: Cardiology; History, 20th Century; Humans; Postoperative Complications; Stents; Ticlopidine | 1998 |
[Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Coron | 1998 |
Ticlopidine and TTP after coronary stenting.
Topics: Angioplasty, Balloon; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl | 1999 |
Ticlopidine and TTP after coronary stenting.
Topics: Angioplasty, Balloon; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl | 1999 |
Studies published on clopidogrel-aspirin for coronary stent placement.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Combinations; Humans; Platelet Agg | 2000 |
Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
Topics: Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Female; Fibrinolytic Agents; Follow-Up | 2000 |
Acute renal failure and thrombocytopenia after ticlopidine--not necessarily thrombotic thrombocytopenic purpura.
Topics: Acute Kidney Injury; Aged; Coronary Disease; Diagnosis, Differential; Embolism, Cholesterol; Female; | 2000 |
Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report.
Topics: Agranulocytosis; Coronary Disease; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Age | 2000 |
Clopidogrel instead of ticlopidine after coronary stent placement: is the switch justified?
Topics: Clopidogrel; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Complic | 2000 |
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coron | 2000 |
Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Cilos | 2001 |
[Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl | 2001 |
[Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial].
Topics: Clinical Trials as Topic; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative C | 2001 |
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Co | 2001 |
Treatment of acute coronary syndromes.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Hemorrhage; | 2002 |
OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey.
Topics: Anticoagulants; Aspirin; Canada; Cardiology; Clopidogrel; Combined Modality Therapy; Coronary Artery | 2001 |
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia; | 2001 |
[Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
Topics: Adult; Aged; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggre | 1989 |
Clinical application of a new in vitro bleeding time device on surgical patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aspirin; Bleeding Time; Epoprostenol; Hemorrhage; Hemostasis; H | 1988 |
[Inhibitory effect of ticlopidine on platelet aggregation in open heart surgery].
Topics: Administration, Oral; Barbiturates; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart Valve P | 1987 |
[Abnormalities of blood coagulation and effect of anticoagulant therapy in postoperative patients with lung cancer].
Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Blood Coagulation Disorders; Female; Humans; Lung | 1986 |
[Efficacy and mechanisms of action of ticlopidine: a drug useful in maintaining aortocoronary bypass patency].
Topics: beta-Thromboglobulin; Coronary Artery Bypass; Humans; Middle Aged; Postoperative Complications; Thro | 1987 |
[Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].
Topics: Blood Platelets; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet A | 1988 |
[Current topics of anticoagulant therapy and antiplatelet therapy after cardiac valve replacement].
Topics: Adolescent; Adult; Aspirin; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Ag | 1988 |
[Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
Topics: Adult; Anticoagulants; Blood Coagulation; Dipyridamole; Female; Heart Valve Diseases; Heart Valve Pr | 1985 |
Ticlopidine as a hemorrhagic risk factor in coronary surgery.
Topics: Adult; Coronary Disease; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Count; Pos | 1985 |